pH Sensitive Anticancer Prodrug: Amide of Kemp's Acid by Brooks, Robert Turongo
 
 
 
http://waikato.researchgateway.ac.nz/ 
 
 
Research Commons at the University of Waikato 
 
Copyright Statement: 
The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). 
The thesis may be consulted by you, provided you comply with the provisions of the Act 
and the following conditions of use:  
 Any use you make of these documents or images must be for research or private 
study purposes only, and you may not make them available to any other person.  
 Authors control the copyright of their thesis. You will recognise the author’s right to 
be identified as the author of the thesis, and due acknowledgement will be made to 
the author where appropriate.  
 You will obtain the author’s permission before publishing any material from the 
thesis.  
 
pH-sensitive Anticancer Prodrug: Amide 
of Kemp’s Acid 
A thesis  
submitted in partial fulfilment  
of the requirements of the degree  
of  
Masters of Science in Chemistry  
at  
The University of Waikato 
by 
Robert Turongo Brooks 
University of Waikato 
2009 
ii 
 
Abstract 
Solid tumours are characterised by lower extracellular pH (as low as 5.8 
pH) compared to normal healthy cellular pH (actively regulated at pH 7.3). 
This difference may be exploited with an acid-sensitive anti-tumour 
prodrug which releases a cytotoxin selectively in tumour tissue. 
The research reported in this thesis was aimed at synthesising and 
performing rate studies on an amide prodrug with pH-sensitive rates of 
reaction in the pH 5 – 8 region. Amide hydrolysis is catalysed by 
neighbouring carboxylic acid groups in their fully protonated state but not 
in its ionised state (shown in the figure below), whereby pH sensitivity 
around pH 5 – 8 can be exploited. The current study was carried out on an 
amide of Kemp’s acid which, due to enforced stereochemistry of carboxylic 
acid and amide functional groups, has the type of structure conducive to 
accelerated amide hydrolysis. 
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The rates for tertiary and secondary aliphatic amides of this Kemp’s acid 
system have shown high reactivity at low pH and a large reduction in rate 
across pH 5.8 – 7.3, however an aryl amide had not previously been 
studied. It was thought that an aryl amide of Kemp’s acid would provide a 
faster rate of reaction compared with the alkyl amides, and also aryl amine 
cytotoxins exist which could be attached as an amide. 
A secondary aryl amide of Kemp’s acid (58) was obtained via a potassium 
hydroxide ring-opening reaction on a synthesised imide of Kemp’s acid 
(43).   
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Aliquots of the ring-opened amide (58) were added to buffered (phosphate 
and malonate) aqueous solutions (with ionic strength µ = 1 mol L-1) and 
the hydrolysis reaction followed at 30.0 oC across the pH range 0.48 - 8. 
First order rate constants were calculated from absorbance change with 
time and the pH-rate profile established. Absorbance changes were shown 
to be consistent with amide hydrolysis with no evidence of any imide 
reformation as evident in other studies. The rate data were analysed. 
There was no evidence from rates for the two successive acid ionisations 
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with only a single rate plateau evident from pH 2 to 5, suggesting that both 
di- and mono-acid species have very similar hydrolysis rates or that the 
second ionisation is low due to stabilisation of the mono-ionised molecule 
by hydrogen bonding interactions. For this reason, the rate profile could be 
analysed only as if it were a single ionisation in the same way that Menger 
and Ladika analysed their aliphatic tertiary pyrrolidyl amide in an earlier 
study. This analysis gave a pKa value of 6.72 ± 0.09 and a limiting rate 
constant of 7.1 x 10-5 s-1. The studies revealed a three fold rate differential 
between pH 5.8 (faster) versus 7.3 (slower), a difference which is probably 
too small a selectivity for possible prodrug application. 
Separately, the second order rate coefficient for the reaction of potassium 
hydroxide solution to open the imide was also established (k2 = 0.00067 L 
mol-1 s-1 at 30.0 oC, µ = 1.00 mol L-1 with KCl). 
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1  Introduction  
1.1 What is cancer?  
Cancer is a collective term used for a group of diseases where cells lose 
the ability to undergo apoptosis (cellular programmed death) resulting in 
unregulated cellular division. Cancerous tumours generally have three 
properties that separate them from benign tumours: 
 Uncontrolled cellular replication 
 Invasion - Where rapidly proliferating cells invade surrounding 
tissues 
 Metastasis – Spread of the cancer throughout the body via the 
blood and lymph systems1 
Cancer can affect both animals and plants, and in humans is responsible 
for approximately 13% of all deaths worldwide.2 It can affect people of all 
ages, though the risk for most forms of cancer increases with age and is 
more prevalent in developed countries where life expectancy is higher.2, 3 
Cancers typically take the form of solid tumours or carcinomas, which 
arise from epithelial cells and account for 80-90% of all cancers, but can 
also take other forms, such as: 
 Sarcoma – Cancerous tumour originating in the bone, cartilage, 
muscle, fibrous connective tissue or fatty tissue 
 Myeloma – Cancerous tumour originating in the plasma cells of the 
bone marrow 
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 Lymphoma – Cancerous tumour originating in the lymph system 
 Leukaemia – Cancer originating in the blood-forming tissue4 
It is widely documented that cancers arise from evolution within a cellular 
population of the body.5-7 This evolution occurs due to genetic errors that 
are accumulated throughout a cell’s life span which causes irreversible 
errors in the genetic makeup of the cell, eventually allowing the cell to be 
free of apoptosis. Errors occur during the replication of DNA, but there are 
mechanisms to prevent cellular division in cases where the genome may 
be extensively compromised, and failure to arrest this development leads 
to the formation of cells with highly unstable genomes that may become 
neoplastic (part of an abnormal mass of tissue), and could possibly go on 
to become malignant.8  
These mechanisms include the activity of enzymes such as DNA 
polymerase which helps to rectify any mistakes that are made to the 
genetic code during DNA replication. Apoptosis is another mechanism, 
where DNA-degrading nucleases are unleashed in the cell, destroying the 
cell’s ability to divide. Apoptosis occurs when a cell is damaged beyond 
repair, infected with a virus or is in a stressful environment such as 
starvation.8  
Even with these correction mechanisms in place, errors still do occur and 
are passed onto subsequent generations of cells. Some of these 
mutations may cause a cell to become neoplastic, providing it with an 
advantage over surrounding cells in that it may be able to replicate faster 
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or more efficiently, thus producing a subpopulation of a new predominant 
cell.5 Progressively more mutations may arise in further generations of 
daughter cells, compounding these initial errors and eventually leading to 
a cell that acts contrary to its intended function in the animal. In this regard, 
cancer is a progressive disease, where errors slowly accumulate in a 
cellular population to a point where a cell may become “immortal” such 
that it is free from apoptosis and can rapidly divide, resulting in the six 
“hallmarks of cancer”:  
 Self sufficiency of cells in signals controlling growth  
 Loss of sensitivity to antigrowth signals  
 Evasion of apoptosis via mutation or loss of tumour suppressor 
genes  
 Development of limitless replicative potential, usually via the 
expression of telomerase  
 Sustained angiogenesis, whereby the blood supply to a tumour is 
augmented 
 Tissue invasion and metastasis, which causes 90% of all cancer-
related deaths.9 
1.1.1 Causes of cancer 
As discussed previously, cancer occurs through acquired genetic 
mutations. There are some areas in the body where there are greater risks 
of mutations and thus a greater risk of cancer. These are areas where 
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cells that are constantly replicating and have high exposure levels to 
carcinogens. The most well documented source of chemical carcinogens 
is tobacco smoke, which has been linked to the incidence of over 90% of 
all lung cancers10, 11 and also to cancers of the paranasal sinuses, 
stomach, liver, kidney and uterine cervix.12 Another is asbestos, with 
prolonged inhalation of asbestos fibres linked with development of the lung 
cancer mesothelioma.13 These carcinogens have a mutagenic effect on 
the genetic material in cells, raising the likelihood of acquiring the 
mutations that cause them to become malignant. Non-chemical 
carcinogens, such as ionising radiation, can also cause mutations to the 
genetic material of a cell. The most well-known type of ionizing radiation is 
high energy ultraviolet light (UV) originating from the sun. High levels of 
exposure to UV radiation have been known to result in high incidence of 
melanomas and other types of skin cancers.14   
It has become increasingly evident that viral infections also play a role in 
the development of cancers, with up to 20% of all cancers worldwide 
stemming from viral infection.15 It is thought that viral infection causes 
insertion of viral DNA into the genome of the host which encodes for 
oncogenes or causes the up-regulation of oncogenes, resulting in a higher 
chance of developing cancer.15 One such virus is human papillomavirus, 
which worldwide is the cause of greater than 93% of invasive cervical 
cancer cases in women16 as well as hepatitis B and hepatitis C which have 
been linked to hepatocellular carcinoma (malignancy of the liver).15 
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Cells that have a high turnover rate have a higher risk of mutations 
because the cellular machinery in place to repair errors made during DNA 
replication is more likely to miss or incompletely repair errors, leading to 
mutations being passed on to daughter cells. 
There are specific genes that become suppressed or expressed at higher 
levels than usual, which are known to affect the occurrence of specific 
cancers. There are two broad groups that encompass the two types of 
genes: oncogenes and tumour suppressor genes. Oncogenes are genes 
that, when expressed at high levels, promote the formation of a cancerous 
cell,17 whilst tumour suppressor genes suppress the formation of a 
mutation that could predispose a cell towards malignancy. A genetic 
mutation may deactivate a suppressor gene such that it cannot have this 
effect.  A classic example of this is the tumour suppressor gene p53. This 
gene was found to play a large role in the suppression of tumours via its 
regulatory role in the cellular cycle.18 Its main means of preventing the 
onset of tumours is preventing genomic mutation by inducing cell cycle 
arrest in response to DNA damage.19 Studies with transgenic mice without 
the p53 gene were prone to spontaneous development of tumours at a 
very early stage of life.20 
1.2 Treatment methods for cancer 
There is currently a wide range of methods for treating cancer, from non-
discriminatory methods such as radiation therapy down to highly specific 
6 
 
methods of treatment such as immunotherapy. Surgery is often used to 
remove tumourous tissue in conjunction with one or more of these 
techniques. The main methods of non-invasive cancer treatment are as 
follows. 
1.2.1 Radiation therapy 
Radiation therapy is a method of treating solid tumours which utilises 
ionising radiation to kill cancer cells. Treatment involves targeting a 
specified area of the body with high energy ionising radiation, which 
damages the genetic material in cells, rendering them incapable of cellular 
division. Total body irradiation is also possible, but as the treatment is not 
selective. Cells surrounding a tumour target will also be damaged leading 
to an increased chance of those cells developing malignancy in later life.  
1.2.2 Chemotherapy 
Chemotherapy is the use of chemicals to treat or control cancer using 
cytotoxic compounds that destroy cancer cells by interfering with their 
growth or preventing their reproduction.4 They work by interrupting the cell 
cycle at specific stages (depending on the drug) and arrest cellular division. 
Chemotherapy treatments are generally more effective against rapidly 
dividing cells, making cancer cells more susceptible as they typically 
undergo rapid cellular division. However, normal body cells can also be 
damaged, with the damaged cells typically being dividing cells such as 
hair cells, bone marrow cells and the cells lining the intestine and mouth. 
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This leads to hair loss, mouth and stomach ulcers, as well as bone marrow 
depletion which can cause immune system depression. There are many 
different chemotherapy agents, each targeting a different aspect of the cell 
cycle such as: alkylating agents, antimetabolites, plant alkaloids, vinca 
alkaloids and topoisomerase inhibitors. Often, a course of treatment will 
require a combination of several drugs from these different classes to try 
and affect as many stages of the cell cycle as possible.4 
1.2.3 Newer methods 
Newer methods of cancer treatment include hormonal therapy, 
immunotherapy and targeted therapy, all of which work by targeting small 
but significant differences between tumour tissue and healthy tissue. 
Targeted therapy is designed to interfere with a specific molecular target 
that is believed to have a critical role in tumour growth and development.21 
The drug imatinib mesylate (marketed as Gleevec) specifically inhibits 
tyrosine kinase enzymes, making it highly effective against chronic 
myeloid leukaemia (CML) and gastrointestinal stromal tumours (GIST). 
This is because CML is caused by a mutant kinase fusion protein Bcr-Abl, 
and GIST is caused by either point mutations in the cytokine receptor c-Kit 
or platelet derived growth factor receptor – α kinases. Imatinib effectively 
inhibits all three kinases halting progression of the cancer, with almost no 
effect on healthy cells. However, this type of treatment is highly 
specialised, and is only effective against a small number of cancers.21   
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Another drug that targets a specific mechanism is angiogenesis inhibitors, 
which inhibit the development of new blood vessels. New blood vessel 
development is necessary for the growth and development of a tumour.22 
These new blood vessels are the primary route of nutrient introduction into 
a tumour and also the primary route that tumour cells exit and metastasise 
throughout the body.23 Typically, new blood vessel development only 
occurs in growing and healing tissue, so in a normal adult this blood 
vessel development is limited to growing tumour tissue allowing inhibiting 
drugs to prevent the growth of a tumour, whilst not effecting healthy tissue, 
by targeting a major difference between tumour tissue and normal healthy 
tissue.  
1.3 Differences between tumour tissue and healthy tissue 
1.3.1 Hypoxia 
Due to the highly disorganised method of blood capillary development in 
tumours there are a significant number of tumour cells that are too far 
away from blood capillaries to allow proper oxygen diffusion into the tissue. 
This leads to these cells becoming hypoxic either temporarily or 
permanently. This was postulated in 1955 by Thomlinson and Gray24 as a 
difference between tumour tissue and healthy tissue. Normal cancer 
treatment methods are sometimes ineffective against hypoxic regions, as 
they are located too far away from blood vessels for adequate diffusion of 
anti-cancer drugs. Because oxygen acts as a radiosensitiser, radiation 
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treatment is less effective against hypoxic tumour cells25, making them two 
to three times more resistant to radiation than those in a non-hypoxic 
environment.26 But because of the difference in oxygen levels that are 
unique to tumour tissue, these hypoxic regions can be targeted by 
prodrugs for anticancer therapies.3,27 
1.3.2 Increased extracellular pH 
Due to disorganised blood capillary development in large tumours, the pH 
is lower than that of surrounding healthy tissue. This is thought to be 
caused by inefficient clearance of acidic metabolic products from 
chronically hypoxic cells which cause the extracellular pH (pHe) to be 
lower than pH 6.3 and as low as pH 5.828, compared to normal pH inside 
cells (pHi) which is actively regulated at pH 7.3.
27, 29 This is one of the few 
well-documented differences between cancer tissue and healthy tissue.30 
Although the magnitude of this pH difference is small it is possible to 
design prodrugs which have higher rates of reaction at the lower pH of 6.3 
than at normal intracellular pH of 7.3. To date there has been relatively 
little work done on exploiting this small pH difference as it is difficult to find 
molecules that have a sufficiently large rate differential at pH 6.3 vs. pH 
7.3. Examples of systems that have been studied will be discussed in 
section 1.4 
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1.4 Prodrugs and studies on possible prodrug systems 
Whilst the methods outlined in the previous section (section 1.2) on 
cancer treatment methods show that the methods can be successful in 
treating cancer, it can also be seen that there is a large number of 
disadvantages of these methods, such as lack of selectivity for cancer 
cells, physiological effects and resistance to the treatment method. In all 
likelihood a universal treatment of all solid tumours is doubtful, however, a 
possible answer to these problems lies in designing drugs which target 
differences between cancerous tissue and healthy tissue.  
Drugs that perform this task, such as the Gleevec example mentioned 
previously (section 1.2.3), have the disadvantage of specificity, that is to 
say they are too specific for use other than against the hormone or 
enzyme they are designed to inhibit. So while they work well for these 
specific cases, the chances of being able to utilise drugs such as Gleevec 
in other anti-cancer scenarios is small. Designing drugs to target less 
specific differences such as hypoxia and pH shows promise, as these two 
differences are unique to tumours.  
An example of drugs being used to target these differences are prodrugs. 
The term prodrug was first coined by Albert31 and is a medicine that is 
administered in an inactive form and is metabolised in vivo into an active 
product. In this broader definition, the clinical drug codeine is a common 
example of a prodrug, as it is demethylated by the liver enzyme CYP2D6 
to morphine. However, for the purposes of this thesis, the interest is in 
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prodrugs that are activated in tumours for anticancer purposes. There has 
been a large amount of interest in these tumour-activated prodrugs 
(TAP)27 because of their potential to release a cytotoxin in conditions 
prevalent in tumours such as hypoxia and lower extracellular pH. In this 
scenario a prodrug would be inactive in the blood stream but upon release 
into a tumour site, be converted into an active cytotoxin with the aim of 
killing the cancerous cells. 
Denny32 proposed a theoretical prodrug structure (Figure 1-1) which 
includes a trigger unit attached to the effector unit (which can be visualised 
as the cytotoxin) via a linker unit.  
Trigger 
   unit Linker unit or mechanism
Effector 
   unit
 
Figure 1-1: Model for prodrug design as proposed by Denny
32
 
1.4.1 Advantages of prodrugs  
An obvious advantage of prodrugs over other antiproliferative agents is 
selectivity. Antiproliferative agents such as cis-platin are effective but are 
limited in their use due to their toxic effects on healthy cells. This is 
because these classes of drugs do not target fundamental changes in 
cancerous cells, but rather changes that occur after these fundamental 
changes, for example rapid cellular division. An advantage of prodrugs is 
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the ability to alter the structure of the prodrug to modify the overall 
pharmacological properties without jeopardising the effectiveness of the 
drug. Because the activation step is the step of primary selectivity, the 
selectivity of the cytotoxin is of lesser concern, and can be chosen from 
simple cytotoxicity tests to be as potent as possible.  
1.4.2 Types of prodrugs 
There are several types of prodrug designs, with each design 
corresponding to a particular set of tumour conditions that would allow 
release of a cytotoxin27: 
i. Tumour hypoxia 
ii. Selective enzyme expression in tumour cells (also other enzyme 
targeted therapies such as ADEPT and GDEPT) 
iii. Radiotherapy 
iv. Tumour specific antigens 
v. Lower extracellular pH 
As the research summarised in this thesis is concerned only with synthesis 
of a pH activated prodrug, discussion of prodrugs will centre on this area 
of research. 
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1.4.3 Prodrugs activated by pH differences 
As discussed in section 1.3.1 the disorganised blood capillary 
development in rapidly growing tumours causes regions of low 
extracellular pH. The reason for this low pH is that metabolic by-products 
in chronically hypoxic regions cannot be extracted by the bloodstream. 
The pH difference between normal tissue and tumour tissue can be up to 
0.8 pH30 and the extracellular pH of a tumour as low as 5.8.28 This is a 
small but significant difference, which can be used as a target for prodrug 
therapies. One mechanism of activation of this type of prodrug would be to 
increase breakdown of the prodrugs at this lower pH found in tumour sites. 
Drugs with this capacity would have the following advantages: 
 Because the activation is non-enzymatic, it would not require the 
presence of suitable activating enzyme systems which may only be 
present in small amounts or at certain stages of the cellular life-
cycle 
 As the activation process is extracellular, the prodrug would be 
designed to be excluded from cells, assisting its diffusion into the 
tumour and also contributing to a large difference in toxicity 
between the prodrug in its non-activated and activated forms.32 
However, due to the small difference between pHi and pHe, relatively little 
work has been done on prodrugs sensitive to this pH difference. Studies 
that have been conducted on systems with potential for pH activated 
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release have yielded few compounds with sufficiently large differences in 
hydrolysis rates in this small pH range. 
The rest of this introduction will examine some studies conducted on 
potential pH-sensitive prodrug systems and the potential for further 
analysis on some of these systems, more specifically on the Kemp’s acid 
molecule. 
1.4.4 Gentamicin system 
An example of a prodrug system is one patented by Eilat and Arad-Yellin 
(2000).33 Their study involved attaching the Gentamicin drug to an acid-
cleavable linkage molecule (3, Figure 1-3). At lower pH this linker group 
cyclises and releases the cytotoxic Gentamicin (Figure 1-2). After being 
dissolved in pH 6.5 buffer for 24 hours, NMR spectral studies on the 
system showed that 25% of the linker molecules (1) had been hydrolysed 
to (2) and so released Gentamicin. The same test for a pH 6 buffer 
showed a 40% hydrolysis rate. In a far more acidic medium (pH = 1), more 
than 90% of the linker molecules were hydrolysed to release Gentamicin 
after 24 hours. 
N
R
OH
H3C
O
H3C CH3
O
H3C
O
+ RNH2
H3C CH3
H2O
(1)
(2)
 
Figure 1-2: pH-sensitive linker group from Eilat patent
33
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Figure 1-3: Gentamicin – pH sensitive linker system
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1.4.5 Glucoside acetal prodrug  
Based on findings that the pH in tumour cells can be decreased by 
stimulation of aerobic glycolysis,34 a glucoside acetal prodrug (6) was 
synthesised. The mechanism for formation of (8) is hydrolysis of (4) to 
yield (5) and (6). The phosphoramide mustard (8) is produced through 
breakdown of the released aldehyde (6), with release of the ester group (7) 
(Figure 1-4). Studying the cytotoxicity of (6) in cultured rat mammary 
carcinoma cells showed that the molecule exhibited little toxicity at pH 7.4, 
but when the environmental pH was lowered to 6.2-5.6 pH, (6) exhibited 
dose-dependent cytotoxicity.   
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Figure 1-4: Mechanism for preparation of glucoside prodrug (6) and subsequent 
breakdown to a phosphoramide mustard (8)
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1.4.6 Amide and carboxylic acid systems 
A number of studies that have been conducted have been centred on 
carboxylic acid-amide related systems, as this makes use of the 
phenomenon that amides undergo accelerated hydrolysis with 
neighbouring carboxylic acid groups (Figure 1-5). In this basic mechanism, 
intramolecular attack occurs by the carboxylic acid group on the amide in 
(9) group which reacts to from an anhydride and amine (11) which is the 
model for the cytotoxin. When the carboxylate group is ionised at higher 
pH, no intramolecular attack occurs so no amine is released (12). 
Therefore this reaction has the potential to be faster at tumour pH than at 
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normal tissue pH. The scheme illustrated show a 4-membered carbon 
chain which cyclises to form the 4-membered carbon cyclic structure. The 
purpose of the linker unit is to enforce proximity upon the functional groups 
that react to release the amine (11) to ensure rapid intramolecular reaction. 
OH
NHR
O
O
O
NHRHO
O
O
O
O
OH
OH
O
O
+ RNH2
Slow
H2O, Fast
Amide with neighbouring 
carboxylic acid group (9)
intermediate (10) anhydride + amine (11)
Di-acid group (13)
NaOH
O
-
NHR
O
O
Amide group with neighbouring 
ionised acid group (12)  
Figure 1-5: Scheme for hydrolysis reaction of an amide by a neighbouring carboxylic acid 
group 
1.4.7 Bicyclic carboxyamides  
Bicyclic carboxyamides are a new class of amides originally studied and 
characterised by Glusenkamp and colleagues35 in 1998. The aim of their 
study was to construct models for new prodrug systems that contained 
tailor-made acid-labile protective groups for pH related activation to be 
used in cancer therapy applications. A wide range of amides were created 
(Figure 1-6, Table 1-1) with substituents that would have a major 
influence on the acid lability of the amide bond (formed synthetically for 
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the study between an amine and an anhydride (14)). In order to maximise 
the amount of structural variety, highly substituted bicyclic anhydrides 
were chosen as precursors to the acid labile amides. Figure 1-6 shows 
the bicyclic anhydride (14) and its corresponding N-methyl tryptamine 
derivatives (14a). All the tertiary amides synthesised were hydrolysed in 
aqueous buffer solution at various pHs to determine their respective half-
lives (Table 1-2). 
X
O
O
O
R
H
H
X
O
O
R
H
H
N
N
H3C
2
3
5
6
2
3
5
6
(14) (14a)  
Figure 1-6: Bicyclic anhydrides (14) and amides (14a) synthesised by Glusenkamp et al
35
 
Table 1-1: Substituents at R and X positions 
Compound 
(X, Xa) 
X R 
14, 14a O CH2-O-COPh; 2,3-exo; 5,6-CH 
15, 15a O CH2-O-COPh; 2,3-exo; 5,6-CH2 
16, 16a O CH2-O-COPh; 2,3-endo; 5,6-CH 
17,17a O CH2-O-COPh; 2,3-endo; 5,6-CH2 
18, 18a O H; 2,3-exo; 5,6-CH 
19, 19a O H; 2,3-exo; 5,6-CH2 
20, 20a CH2 H; 2,3-endo; 5,6-CH 
21, 21a CH2 H; 2,3-endo; 5,6-CH2 
22, 22a CH2-CH2 H; 5,6-CH2 
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Table 1-2: Cleavage rates of the N-methyl-tryptamine adducts 14a - 22a 
Compound pK(app) t1/2 at pH 5 
(minutes) 
t1/2 at pH 6 
(minutes) 
t1/2 at pH 7 
(hours) 
14a 4.6 67 336 39 
15a 4.6 17 106 14 
16a 4.7 312 1560 208 
17a 4.5 155 930 124 
18a 4.5 31 159 21 
19a 4.6 10 52 7 
20a 5.4 2 13 1.7 
21a 5.4 2 13 1.7 
22a 5.9 0.3 0.5 0.04 
 
From these data, it can be seen that all amides display much smaller 
cleavage half-lives at pH 5 than at pH 6 and these than at pH 7. Molecules 
with the CH2 group at the X position showed the smallest half-lives, with 
molecule (22a) showing a half-life of 2.6 minutes at pH 7. Molecules (20a) 
and (21a), which are endo, show slightly slower t1/2. Those with oxygen at 
the bridging X position have longer half-lives with the exo isomers having 
the shorter half-lives; however the endo isomers show the smallest half-
lives with CH2 as the bridging group. The reasons for these differences are 
not explored in the published paper other than stating that that a 0.15 Å 
difference in distance from the acid carbonyl carbon to the adjacent amide 
carbonyl carbon is responsible for the difference in reactivity between (22a) 
(2.79 Å) and (16a) (2.94 Å). A possible reason for the difference in 
reactivity with oxygen as the bridging group is the rigid stereochemistry of 
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the functional groups at carbon positions 2 and 3. Overall this study 
showed it was possible to synthesise a wide variety of structures, all 
showing decreased activity at pH 7 compared to the lower pHs of 5 and 6. 
The molecules that have the oxygen bridge (specifically those with exo 
isomer) show more promise with respect to prodrug application as they 
have half-lives at pH 6 that would allow them to activate preferentially in a 
tumour. 
1.4.8 Maleic amides 
It is known that amides of maleic acid undergo hydrolysis in their neutral 
form to form maleic anhydride and release amine in a method akin to that 
shown in (Figure 1-5), although for an ionised maleic acid hydrolysis 
occurs albeit slowly. This leads to a plateau in the pH rate profile below pH 
3, with the pKa being approximately 3.5. Although this is too low for any 
potential prodrug application, the rates of reaction for this compound can 
be increased by the modification of groups on the double bond. An 
example of this is a Daunorubicin (DNR) conjugate system synthesised 
and studied by Dillman et al (Figure 1-7).36 This system involved the 
attachment of the anticancer agent Daunorubicin and the monoclonal 
antibody T101 to a maleic acid amide which acts as an acid-sensitive 
linker group between the two. Tests were done measuring absorption (475 
nm, for free DNR) in buffer solutions at 37 oC (with incubation periods of 
one, two, four, 24 and 48 hours) at pH 3, 4, 5, 6, 7 and 8. 
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Figure 1-7: Daunorubicin (DNR) - maleic acid amide – T101 Monoclonal Antibody 
conjugate
36
 
The highest absorptions were seen at pH 3 and 4, corresponding to nearly 
100% drug release, with absorption decreasing to nearly zero for solutions 
at pH 7 and 8 (0% release), while at ph 5 there was roughly 50% release, 
thus confirming the pH sensitivity of this compound. Also studied was the 
difference in anti-tumour effect of the conjugate compared to the free 
Daunorubicin drug. This experiment was conducted in athymic mice 
bearing human tumour xenografts (MOLT-4 cell-line). The experiment was 
designed to test the effectiveness of the two systems on tumour size. The 
mice were treated with equal doses of the conjugate DNR-maleic amide-
T101a system (23), DNR-T101 and DNR by itself. The conjugate system 
showed vastly decreased tumour size relative to the stand-alone 
Daunorubicin drug. 
1.4.9 Cyclopentane tetracarboxylic acid amide 
Cyclopentane systems with four all-cis carboxylic acid groups were studied 
by Billett and colleagues37 with the intention of finding the potential of such 
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systems for prodrug use. Studies with this system were initiated as the 
problem with the mechanism in Figure 1-5 is that hydrolysis slows with 
increasing pH, as the amount of the non-reactive conjugate base (12) 
increases; with pKa values of carboxylic acids seldom being above 4.5, 
monocarboxylic acids are nearly completely ionised below pH 5.5 and 
rates of amide hydrolysis become low tending towards neutral pH as the 
amount of neighbouring carboxylic acid group in a catalytic free form 
decreases. However three carboxylic acid groups elsewhere in the amide 
structure raise the second and third pKa and ensure that close to pH 7 
there are still available some undissociated COOH groups to react 
intramolecularly to form the intermediate (24).37  
Two diacid imides were synthesised (25a, 25b) (Figure 1-8) to test the 
rate of reactions of the compounds at pD 5–7 in aqueous D2O buffer. The 
amides were formed by ring-opening of the imides with NaOD and then 
neutralisation. Analysing the reaction of the tri-acid amide (24) by NMR 
showed that the major product of the reaction was the imide product (25a), 
whilst the sought after hydrolysis reaction that releases amine (26) was 
minor (an example of one of the studied reactions is shown in Figure 1-9). 
This thwarted the possibility of prodrug applicability of these cyclopentane 
systems.  
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Figure 1-8:The two diacid imides synthesised by Billet et al
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Anhydride + 
Amine (26)
diacid imide (25a)
Ring opening by NaOH
reacted at
pD 5 - 6.5
 
Figure 1-9: Imide reformation as the major product as opposed to hydrolysis for imide 
(25a)
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1.5 Kemp’s acid 
Kemp’s acid (cis,cis-1,3,5-trimethylcyclohexane-1,3,5-tricarboxylic acid) 
(27, Figure 1-10) was initially synthesised and characterised by Kemp and 
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Petrakis (in the all cis conformation).38 The interest in prodrug potential for 
this compound comes from the enforced proximity of the three acid groups 
which occurs as the methyl groups on the molecule prefer to stay in the 
equatorial position which is its preferred conformation, proven by x-ray 
analysis.39 Flipping into the other chair conformation has been reported40 
for a di-aryl amide Kemp’s acid compound.  
Important for acid-sensitive prodrug application is the presence of the two 
carboxylic acid groups in a mono-amide derivative which would ensure 
that at a pH around pHe, there would be sufficient unionised acid groups 
available to promote facile hydrolysis of the amide to form anhydride and 
amine; but rate would die off with increasing pH as the second acid group 
ionised. Herein exists potential pH-sensitivity in the pHe zone. At low pH 
the diacid would not be ionised at all so individual rates of the neutral, 
mono- and di-ionised species would determine a composite pH-rate profile.  
COOHCOOH
H3C
COOH
H3C
CH3
(27)
 
Figure 1-10: Kemp's acid in the cis,cis conformation 
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1.5.1 Studies on reaction rates and structural effects on reaction 
rates 
Previous studies support the above potential for the amide hydrolysis 
reaction, as this reaction has been shown to occur quickly at neutral pH 
and also show a large pH-based differential in rate for some aliphatic 
tertiary and secondary amides.  
Menger and Ladika41 conducted a study on the rate of intramolecular-
catalysed cleavage of an aliphatic tertiary (pyrrolidyl) amide under 
biological conditions (ambient temperature of 21.5 oC, neutral pH) in an 
attempt to find a model for the rapid cleavage of peptide amide bonds 
exhibited by the enzyme peptidase. Starting for convenience with the 
anhydride (28) in D2O they monitored the formation of (29) and from it (30) 
by NMR spectroscopy (Figure 1-11), both reactions as a function of pH. k1 
was larger and it increasingly diverged from k2 as pD was reduced from 9. 
This study showed that that the amide cleavage of (29) to yield (30) occurs 
with a t1/2 of eight minutes at pH 6.9 at which pH, from a calculated pKa of 
6.9, (29) would be approximately 50% in mono and di-ionised state. 
H3C
H3C
CH3
OO
O
COOH
COOH
H3C
H3C
CH3 H3C
H3C
CH3
OO O
COOH
k1 k2
(28) (29) (30)
O N O N
N
+
 
Figure 1-11: Acylolysis reaction studied by Menger and Ladika
41
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Diacid amide (29) was assumed to be the active species as the extremely 
fast rate of reaction was suggested as possibly due to the conformation of 
(29). Molecular mechanic calculations showed that an interaction that may 
play a large role in this observed rate of reaction is the distance between 
the amide carbonyl carbon and the acid hydroxyl group which is 2.80 Å 
((29b) Figure 1-12). In both situations, there is an almost ideal Dunitz 
“attack angle” (Oa/Cb/Oc (Figure 1-12)) of 105
o.42 Also, the carboxyl group 
is positioned well for synchronous nucleophilic attack and proton delivery. 
Another intramolecular distance that could affect the reactivity is the 
distance between the amide carbonyl carbon and the acid carbonyl carbon, 
with the distance being 2.78 Ǻ ((29a) Figure 1-12).  
OH
O
N
COOH
2.78A
Oa
Cb
Oc
N
COOH
O
H
3.78A
2.80A
(29b)
(29a)
 
Figure 1-12: Intramolecular distances between adjacent carbonyl groups showing 
movement around C3-C3’ bond (calculated using MACROMODEL)
41
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Full rate profiles for both k1 and k2 were determined, with amide cleavage 
occurring much faster than anhydride hydrolysis (k2/ k1 = 150 at pD = 7.05, 
21.5 oC). Also discovered in this study was that for the small half-life 
illustrated above, only one of the carboxyl groups is needed to participate 
in the amide cleavage. This was established by synthesising an acid-
amide-ester (31) which underwent amide cleavage rather than ester 
cleavage (Figure 1-13), with a t1/2 = 5 minutes (pD = 6.3, 21.5 
oC), which 
compares well with the half-life for a diacid amide.  
COOCH3
COOH
H3C
H3C
CH3
N O
COOCH3
H3C
H3C
CH3
OO
O
(31) (32)
+
N
 
Figure 1-13: Acid-amide-ester hydrolysis reaction 
Building upon the research conducted by Menger and Ladika was a study 
by Curran et al43 comparing the acylolysis rates of secondary and tertiary 
aryl amides of Kemp’s acid (Figure 1-14). This study established that the 
rate constant for acylolysis in D2O at pD 7 for the tertiary amide derivative 
(33a) of Kemp’s acid was 1000 times higher than that for a corresponding 
secondary amide (33b). The half-life of the synthesised tertiary amide was 
very similar to that reported by Menger and Ladika, with t1/2 = 5.3 min (pD 
= 7, 22 oC). 
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Figure 1-14: Acylolysis of a tertiary amide (R = CH3) versus a secondary amide (R = H)
43
 
A pH rate profile from pD 4 - 9 was plotted to compare the acylolysis rates 
of the tertiary and secondary amide. This showed that (33a) has reaction 
rates between two to four fold faster than (33b) over the entire pD range. 
For example at pD 4.8 (22 oC), t1/2 = 10 hours for (33b), whereas for (33a), 
the half-life is 1.9 minutes, a reaction rate 300 times faster than that of 
(33b). At pD 7.0, the rate difference is even faster, with (33a) having a t1/2 
= 5.4 min, while for (33b) t1/2 = 270 hours, a 3000 fold reactivity difference.  
Also investigated was the effect of substitution at one of the carboxylic 
acid groups for comparison with the study previously illustrated. This 
involved converting the carboxylic acid group to a methyl ester group 
(Figure 1-15).  
COOH
H3C
H3C
CH3
COOMe
O N
H
CH2CH2Ph
H3C
H3C
CH3
OO O
COOMe + PhCH2CH2NH2
R = H, CH3
(35) (36)
D2O buffered solutions
 
Figure 1-15: Amide acid methyl ester compound studied by Curran et al
43
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The full pH-rate profile (pD 0 – 8) for the methyl ester (35) showed roughly 
the same reaction rates as the original secondary amide (33b), so 
substitution has a negligible effect on the rate of reaction, confirming the 
experiments conducted by Menger and Ladika. The tertiary analogue of 
(35) could not be isolated for a similar study due to its high reactivity. 
It was also found that the cis,cis ester (33b) exhibits a 100 fold faster rate 
between pH 5 and 6.3 than the cis,trans isomer (Figure 1-16). The pH 
rate profiles for (37a) and (37b) were plotted, and showed that the 
cis,trans tertiary amide underwent acylolysis up to 100 times faster than 
the secondary amide.  
COOH
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CH2CH2Ar
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CH3
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CH3 + ArCH2CH2NHR
(38)
Ar = 3,4-dimethoxyphenyl
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(40)
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(39)  
Figure 1-16: cis,cis secondary amide and cis,trans tertiary and secondary amides studied 
by Curran et al
43
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The rates showed greater differences than expected if, as Menger and 
Ladika stated, only the proximity of carboxylic acid groups and some 1,3-
diaxial strain was postulated as responsible for the amount of 
intramolecular catalysis observed. Examination of space-filling models for 
(33a), (33b), (37a) and (37b) revealed the presence of so-called 
pseudoallylic strain associated with the amide, arising from interaction 
between the N-substituents trans to the C=O bond and the alkyl 
substituents on the tertiary cyclohexane carbon α to the amide. For the 
tertiary amide these interactions may be large enough to cause distortion 
of the amide bond, which is known to accelerate amide hydrolysis.44 This 
is proposed as the main cause of rate acceleration for tertiary amides, 
causing up to 105 times rate acceleration where it is present. A study by 
Dougan et al45 found the same pseudoallylic strain to contribute to the 
reactivity of their piperidyl Kemp’s acid derivative, though they could not 
quantify accurately the amount of strain relief. Another study conducted in 
2006 by Gershler et al46 disputed the large value stated by Curran et al43 
estimating that pseudoallylic strain relief contributes only a 2400 fold rate 
increase in amide bond cleavage. 
1.5.2 Doxorubicin system 
Doxorubicin is marketed under the name Adriamycin and is a 
chemotherapy drug used for cancer treatment. Whilst it is effective against 
a wide range of cancers it is hindered in its effect by its dose-dependent 
toxicity, especially its cardiotoxicity.47 In an effort to try and improve its 
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effectiveness, a study was conducted by Dubowchik et al48 on attaching 
doxorubicin to an amide of Kemp’s acid creating an acid sensitive prodrug. 
They studied the rate of doxorubicin release at neutral pH (pH 7) versus 
lysosomal pH (pH ≈ 4.8). Lysosomal pH was used as it was hoped that 
this type of drug could be targeted at being released inside lysosomes in 
cells. The molecule would be able to enter the cell via endocytosis using 
specially created monoclonal antibodies.49  
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Figure 1-17: Doxorubicin-Kemp's acid/ Kemp’s acid amide conjugate
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Table 1-3: Effect of various R groups on the rate of doxorubicin release
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Compound (41a) (41b) (41c) (41d) 
R H H COCF3 H 
R’ COOH CONHBu CONMeBu COOMe 
t1/2, pH 5, 37 
oC 30h 90h >174h 40h 
t1/2, pH 7, 37 
oC -- >160 days > 174h >100 days 
 
The doxorubicin molecule was attached as an amide to one of the 
carboxyl groups (Figure 1-17), and in three of the derivatives a second 
acid group was converted to another amide or to an ester (Table 1-3). A 
second amide or ester group was placed at the R’ position to see what 
effect it would have on the overall rate of the hydrolysis reaction. 
Compound (41d) with amide and methyl ester groups was found to have 
the best combination of reaction rates for the hydrolysis leading to 
doxorubicin release, being extremely unreactive at neutral pH whilst 
having a half-life of forty hours at pH 5. Thus molecule (41d) shows great 
potential for not only prodrug application, but the use of Kemp’s acid 
amides as acid-sensitive linkers in prodrug use. However no further 
studies on this molecular system have been published; it seems that 
further work that has been done with doxorubicin is to do with linkages to 
molecular polymers, the study of which is outside the realms of this thesis. 
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1.5.3 Planned research work 
The research work planned for this thesis was the attempted syntheses 
and characterisation of a cis,cis Kemp’s acid aryl mono amide and its 
consequent kinetic study for construction of a pH rate profile. To our 
knowledge, no kinetic study of hydrolysis of any aryl amides of Kemp’s 
acid has been reported. 
An aryl amide was chosen also over an alkyl amide, as being more 
applicable from a prodrug point of view as aryl amine cytotoxin groups 
exist that could be attached to the Kemp’s acid molecule to form a prodrug 
for accelerated cytotoxin release into low pH tissue. The absolute rates for 
an aryl amide of Kemp’s acid relative to an aliphatic amide are unknown. 
However studies with amides of maleic acid50 show the secondary aryl 
anilide  to be four to five times more reactive than the secondary aliphatic 
methylamide but 10 times less reactive than the tertiary aliphatic 
dimethylamide.  
Mechanistic differences exist between neighbouring-carboxyl-catalysed 
hydrolysis of aliphatic and aryl amides51 but the initial expectation might be 
from the above that a secondary aryl amide of Kemp’s acid would be 
perhaps 10 times less reactive than the tertiary amides previously 
studied.41, 43 However in the work done by Curran et al43, his secondary 
aliphatic Kemp’s amides were about 1000 times less reactive than the N-
methyl tertiary analogues but this was accounted for by a special 
pseudoallylic strain effect proposed to distort the amide bond in the tertiary 
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case. This leaves the Kemp’s tertiary amide system as a special case, but 
for secondary amides the data from Aldersley et al50 could be used to 
predict that a Kemp’s secondary aryl amide might be perhaps four to five 
times more reactive than the Curran secondary aliphatic amides. This 
looks to be rather slow for prodrug application, but that ignores the 
essential differences that the Kemp’s scaffold might provide relative to the 
maleic system studied by Aldersley et al.50 
For this study both tertiary and secondary aryl amides were contemplated. 
The hydrolysis of the aryl amide is also a relatively simple reaction to 
monitor as the N-aryl group in the molecule is UV-absorbing but much less 
than the corresponding aryl amide, so that the hydrolysis of the aryl amide 
group will result in strong UV changes, which allow spectrophotometric 
monitoring. By comparison with NMR monitoring, UV has the advantage 
that much more dilute samples in fully buffered aqueous solutions can be 
used and with stringent temperature control in a thermostatted cell block in 
the spectrophotometer. This method is also far more reliable for data 
reproducibility than removing samples for chromatographic analysis as 
carried out by Curran et al.43  
The aim was that once an amide was synthesised, rate studies would be 
conducted to construct a pH rate-profile, encompassing the three different 
ionisation states of the triacid amide. 
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2 Synthesis of an amide of Kemp’s acid 
2.1 Introduction 
As explained in the introduction, Kemp’s acid amides show good promise 
for prodrug application. However, no Kemp’s acid amides are readily 
available from any commercial sources, so must first be synthesised from 
Kemp’s triacid. This synthesis can be divided into two parts; first the 
synthesis of the Kemp’s anhydride acid chloride and then secondly the 
use of the anhydride acid chloride to synthesise the desired amide.  
As the following discussion shows, initial attempts at directly synthesising 
a tertiary aryl amide using N-methylaniline were unsuccessful. To obtain a 
secondary aryl amide, the way around difficulties with the direct route from 
acid chloride was to first synthesize and purify an imide of Kemp’s acid, 
from which the imide ring functionality could be opened in hydroxide 
solution to yield the secondary amide as the stable dianion, in which state 
it could be stored in aqueous alkaline solution until required for kinetic 
study at low pH (Figure 2-1).  
The intention after successful synthesis was to determine a full pH-rate 
profile in the pH 4 – 8 region for the diacid amide so that contributions 
from the three different ionised species (the neutral, mono-ionised and di-
ionised species) could be established, something which had eluded earlier 
studies with Kemp’s aliphatic amides. Because the secondary amide could 
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allow reversion to imide to occur in competition with hydrolysis, checks to 
determine if this occurred were also planned for. In previous studies this 
was not an issue because the amides were tertiary. 
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Figure 2-1: Overall synthesis method from Kemp's triacid through to the diacid amide 
2.2  Preparation of Kemp’s anhydride acid chloride 
Kemp reported a method for synthesis for anhydride acid chloride38 using 
excess thionyl chloride (SOCl2) under reflux for four hours, after which 
excess reagent and solvent were evaporated off and then the resultant 
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product crystallised from toluene. This in principle could have given a tri-
acid chloride; however, the anhydride acid chloride was formed suggesting 
that it may proceed through the mechanism in Figure 2-2:  
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Figure 2-2: Formation of anhydride acid chloride using thionyl chloride 
In the current study this method was adopted but instead of SOCl2, oxalyl 
chloride (COCl)2 was used, which leaves less residue after the excess 
reagent is removed. Checks to ensure the reagent change did not produce 
tri-acid chloride were made by IR spectroscopy. There are three previous 
reports of IR data for the acid anhydride which were used for reference 
frequencies. Menger and Ladika41 reported 1793 cm-1 and 1770cm-1 for 
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the anhydride and acid chloride groups of their anhydride acid chloride. 
Ikeura and colleagues52 reported a single absorbance at 1773cm-1 but 
may have ignored a weak absorbance around 1790cm-1. In Kemp’s initial 
study, he reported a wavelength of 1780cm-1. The discrepancy in 
wavelengths may come from variation in IR resolution. Reported melting 
points were in the range of 255-260oC. These two methods of initial 
monitoring were useful checks prior to structural confirmation by NMR 
spectroscopy. 
The anhydride acid chloride is water sensitive, and any water present 
during the reaction or on workup will cause hydrolysis with loss of acid 
chloride if not anhydride. All glassware was dried in an oven in advance 
and the reaction vessel was fitted with a calcium chloride drying tube. Dry 
dichloromethane was used as the solvent, as the triacid in insoluble in this 
medium due to its (three) acid groups, but the product of the reaction, the 
anhydride acid chloride is soluble, so this provides a handy measure for 
assessing the completion of the reaction.  
2.2.1 Results 
This reaction yielded crude white crystals that were initially analysed by 
melting point and IR spectroscopy. The melting point range of the impure 
crystals was 245 -248oC, slightly lower than literature values. IR analysis 
in the carboxyl region further confirmed that the desired product had been 
formed along with some impurities, showing the expected peaks at 1770 
and 1802cm-1 with another peak at 1746cm-1 all within the range predicted 
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from earlier studies. A peak was also present at 1850cm-1, which can be 
attributed to (COCl)2, however using IR to determine if any (COCl)2 was 
present was difficult as (COCl)2 gives two peaks at 1781 an 1850cm
-1 that 
may overlap with those of the anhydride acid chloride. Overall, these initial 
methods showed that anhydride acid chloride had been formed but there 
were impurities present, so a recrystallisation with dichloromethane was 
undertaken. Fine white crystals were obtained which were analysed by 
NMR, which showed peaks that matched those from the literature53 and no 
evident impurities, thus providing final confirmation that pure anhydride 
acid chloride product sufficiently pure for the next stage had been formed. 
Another melting point was taken, showing an improved melting point of 
253 – 255oC, closely matching those reported by the literature54. 
2.3 Attempted synthesis of a tertiary aryl amide 
2.3.1 N-Methylaniline method 
Tertiary aliphatic amides of Kemp’s acid show much greater reactivity than 
secondary amides, so the synthesis of a tertiary aryl amide of Kemp’s acid 
was the next logical step for this study. 
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Figure 2-3: Synthesis of a tertiary Kemp's amide using N-methylaniline 
Synthetic methods for tertiary aliphatic amides have varied. Curran and 
colleagues used a combination of N-methylphenethylamine and 
triethylamine in dichloromethane in the synthesis of their variety of tertiary 
alkyl amides.43 From the anhydride acid chloride, Menger and Ladika41 
used dry pyridine and pyrrolidine to synthesise tertiary pyrrolidine acid 
amides. In each case a base was present in excess to remove 
hydrochloric acid produced. For this study, it was decided that N-
methylaniline should be used (Figure 2-3). During this reaction, one mole 
of hydrochloric acid (HCl) is formed, which will react with N-methylaniline 
to form the salt (51) if there is no other base present, so two moles of the 
amine N-methylaniline are needed, to ensure a complete reaction. The 
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downside of this is that any product formed (50) will be contaminated with 
the amine salt (51). 
The preliminary study of the reaction was carried out in deuterated 
chloroform in an NMR tube so that the reaction could be monitored by 1H 
NMR. The absence of any N-methylaniline amide signals around 7.4 and 
7.1 ppm54 showed no reaction at room temperature after two hours. 
Triethylamine, as used by Curran et al43, was then added to potentially 
promote the reaction through base catalysis of the nucleophilic attack of 
N-methylaniline on the anhydride acid chloride. The solution was heated 
under reflux for two days, and still no reaction was found to have occurred. 
The lack of reaction is consistent with much reduced basicity and 
nucleophilicity if aryl amines relative to aliphatic amines. 
2.3.2 Use of butyllithium to generate a more reactive amide ion 
It was decided to utilise butyllithium (BuLi) (52) to deprotonate the N-
methylaniline (Figure 2-4), and increase its nucleophilic reactivity prior to 
its reaction with the anhydrous acid chloride. Both reactions needed to be 
free of water vapour so that BuLi and the anhydride acid chloride do not 
hydrolyse. All glassware was dried prior to use and fitted with drying tubes, 
and both reactions were conducted under nitrogen. This reaction was 
conducted at low temperature (-40 oC) on a 1,2-dichlorobenzene slush 
bath in an attempt to maximise selectivity of N-methylaniline for acid 
chloride over less reactive anhydride. For the first attempt, dry 
dichloromethane was used as the solvent in both stages, but the reaction 
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to form the tertiary amide did not occur in this medium. The possibility of a 
side reaction of the amide as base on dichloromethane to form a 
chlorocarbene could not be excluded, so both steps were again attempted 
with sodium-dried diethyl ether solvent. 
2.3.2.1 Deprotonation reaction 
H
N
Me
Li+
N
Me
Li
+
(49) (52)
(51) (53)  
Figure 2-4: Deprotonation of N-methylaniline (49) by n-BuLi (52) 
The N-methylaniline was dissolved in the dry solvent in the reaction vessel 
and n-BuLi solution (in cyclopentane) in dry diethyl ether solvent was 
injected into this solution dropwise with stirring. This resulting pale yellow 
solution was placed in the refrigerator overnight in preparation for the next 
phase of the reaction. 
2.3.2.2 Reaction of deprotonated N-methylaniline with anhydride acid 
chloride 
This step of the reaction was also conducted on a low temperature slush 
bath, so that the desired anhydride amide product (54) did not react with 
(51) again to form any acid diamde (55) (Figure 2-5). For the first attempt 
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at this reaction, the anhydride acid chloride was dissolved in the dry 
dichloromethane, and the lithium amide (51) added slowly (1.3 x excess to 
allow a margin for trace water contamination).  
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Figure 2-5: Formation of tertiary amide from deprotonated N-methylaniline 
Addition of all the deprotonated amine caused the solution to turn a dark 
brown colour. Upon completion of the addition, the solution was left to 
stand overnight at room temperature. Some brown crystals had settled out 
of the solution. The supernatant was removed and analysed as a solution 
spectrum by IR. The spectrum showed no expected amide peaks and 
peaks were seen that matched the initial anhydride acid chloride peaks. 
NMR analysis was also conducted in a last attempt to see if any product 
(54) had been formed. The peaks observed were characteristic of an 
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amine, and there was no sign of the N-methylaniline signal of an amide. 
The brown crystals were washed with dry dichloromethane and then 
distilled water. An IR spectrum of these crystals also showed no amide 
peaks as compared to literature values37, 41 which are in the range of 
1600-1630cm-1.  
When the NMR solution was left to stand overnight, a white suspended 
solid had formed on top of the solvent surface, possibly some unreacted 
Kemp’s acid or a salt such as lithium chloride (Li+Cl-).  
2.3.3 Imide synthesis 
After the previous failings of trying to synthesise a tertiary amide derivative 
of Kemp’s acid directly, it was decided to first synthesise an imide to act as 
an “intermediate” that could then undergo a ring opening reaction to form 
an acid amide. In this case however, it would be a secondary amide 
(Figure 2-6), so a subsequent test to ensure the amide did undergo 
hydrolysis rather than reform imide around neutral pH would be needed. 
This method has been used by Rebek et al 39 who reacted the anhydride 
acid chloride with a one molar equivalent of aniline and a catalytic amount 
of dimethylaminopyridine (DMAP) in pyridine. 
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Figure 2-6: Synthesis of an amide of Kemp's acid via an imide and subsequent ring 
opening to form a diacid secondary amide 
This imide could then serve as the reactant for a ring opening reaction, in 
NaOH in which the imide hydrolyses to yield a diacid amide ((44) in Figure 
2-6) which is a stable form of the substrate needed for hydrolysis study at 
lower pH.  
The imide (43) was successfully prepared using p-anisidine as described 
in the experimental section after a prolonged reaction under nitrogen at 95 
oC for a week. 
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2.4 Experimental 
1H NMR spectra were collected at either 300 MHz on a Bruker Avance 300 
FT-NMR or at 400 MHz on a Bruker Avance DRX400 FT-NMR 
spectrometer. Infra-red spectra were recorded either as a solid disc with 
KBr or as liquid solution spectra between KBr discs on a Perkin-Elmer 
spectrum 100 FT-IR spectrometer. Melting points were obtained on a 
Reichart-Jung Thermavar microscope thermometer. Elemental analysis 
was carried out by the Microanalytical laboratory at Otago University. 
2.4.1 Anhydride acid chloride (42) 
Kemp’s triacid (0.5 g, 1.95 mmol) was dissolved in dry dichloromethane 
(20 mL) as solvent. A five times excess of oxalyl chloride was added 
dropwise (1.68 mL, 9.75 mmol). This reaction solution was heated under 
reflux on an oil bath set at 55 oC until all of the Kemp’s triacid had 
disappeared, indicating the completion of the reaction of Kemp’s triacid to 
the soluble anhydride acid chloride. The resulting solution was left to cool 
overnight. Some crystallisation occurred and the remaining solvent was 
removed by rotary evaporation. This yielded crude white crystals. 
Purification was achieved by dissolving the crude product in dry 
dichloromethane (10 mL), again refluxing until all of the crude crystals 
dissolved. Excess solvent was again removed by rotary evaporation and 
then on a vacuum line. The anhydride acid chloride was isolated as fine 
white crystals (0.253 g. 50%, m.p. 253 - 255 oC). 1H NMR (300 MHz) 
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(CDCl3) (numbering scheme illustrated in Figure 2-7): δ 1.25 (d, J = 14.37 
Hz, 2H, axial H2, H6), 1.32 (s, 3H, H1’), 1.34 (s, 6H, H3’, H5’), 1.37(d, J = 
14.91Hz, 1H, axial H4), 2.02 (d, J = 1.83 Hz, 1H, equatorial H4), 2.74 (d, J 
= 13.76 Hz, 2H, equatorial H2, H6). IR (liquid solution in CH2Cl2): 1746 
(anhydride C=O), 1770 (anhydride C=O), 1802 cm-1 (acid chloride C=O). 
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Figure 2-7: Anhydrous acid chloride, numbered for NMR assignments 
2.4.2 Attempted tertiary amide acid synthesis using N-methylaniline 
The N-methylaniline was distilled prior to the reaction, collecting a middle 
fraction (b.p. 194-196oC). The anhydride acid chloride (48.5 mg, 0.187 
mmol) was dissolved in deuterated chloroform (3 mL). A sample of this 
solution (0.031 mmol) was placed in an NMR tube to which a twofold 
excess of N-methylaniline was added (6.8 µL, 0.062 mmol). After two 
hours the solution was analysed by NMR which showed the methyl signal 
of amine but not of amide peaks around 7.4 and 7.1 ppm54, indicating that 
no reaction had occurred. Triethylamine was therefore added in a 1.5 fold 
excess relative to N-methylaniline (13.1 µL, 0.94 mmol). This solution was 
heated under reflux in a nitrogen atmosphere for two days and then re-
analysed by NMR spectroscopy. This showed strong signals from 
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triethylamine and also N-methylaniline but once again not the desired 
methyl amide peak. 
2.4.3 Attempted tertiary amide acid synthesis using deprotonated N-
methylaniline 
N-Methylaniline (165 µL, 1.52 mmol) was placed in diethyl ether (AnalaR, 
6 mL) which had been dried over a weekend with sodium wire. n-
Butyllithium in cyclopentane solution (0.76 mL, 1.52 mmol) was added 
slowly to the ether solution, cooled in a 1,2-dichlorobenzene slush bath at 
-40 oC. 
Kemp’s anhydride acid chloride (0.253 g, 1.17 mmol) was dissolved in dry 
diethyl ether (30 mL) and cooled to -40 oC in a dichlorobenzene slush bath. 
The lithium amide (51) solution (6 mL) was added dropwise via syringe to 
the anhydride acid chloride solution. This was reacted on for two hours 
with a drying tube fitted to the reaction solution. After leaving to stand 
overnight, crystals had formed in the solution along with supernatant. The 
supernatant was removed and initial analysis was achieved by IR, which 
showed no amide carbonyl peaks. An NMR spectrum was taken which 
showed peaks representative of the N-methylaniline and Kemp’s 
anhydride acid chloride, showing no signs that an amide had formed.  
The separated crystals were taken and then washed in a separating funnel 
with dry diethyl ether (40 mL) and then distilled water (20 mL). These 
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cleaned crystals were then dissolved in CDCl3 and analysed by IR, once 
again showing no amide peaks. 
2.4.4 Synthesis of an Imide of Kemp’s acid (43) 
Pyridine (AnalaR) was distilled over KOH and dried with oven-dried 3A 
type molecular sieves. p-Anisidine was doubly recrystallised from ethanol, 
and vacuum dried. The anhydride acid chloride was dissolved in pyridine 
(5 mL), to which p-anisidine (1.2 mol equivalent, 0.298 g), and a catalytic 
amount of dimethylaminopyridine (0.03 g) was added. The solution was 
heated at 95 oC for seven days under nitrogen. 
 A 1 mL sub-sample was taken and extracted by the scheme outlined 
below, which was adapted from a similar extraction method used by 
Rebek et al39. This method of extraction yielded brown crystals. These 
crystals were then analysed by IR and 1H NMR spectra (in CDCl3). The 
NMR spectrum of the sample showed that the imide product had been 
formed along with some impurities. After the initial NMR, a white solid had 
formed on top of the CDCl3 solution. The solid was removed and analysed 
by IR and melting point analysis and was found to be Kemp’s acid, 
showing that in the reaction mix some of the original material had been 
reformed presumably by hydrolysis of acid chloride. 
The remainder of the reaction solution was then extracted. The extracted 
solution had excess solvent removed by rotary evaporation which yielded 
light brown crystals which were analysed by NMR. The spectrum showed 
that this product was much cleaner than the sub-sample analysed 
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previously, and contained only the desired imide product, as assessed by 
comparison39 with reported the spectrum for a close analogue with a butyl 
group in place of methoxy on the aromatic ring. The ring opening reaction 
will be covered in the next chapter, as it falls under kinetic analysis. 
Recrystallisation was carried out in ethanol (AnalaR) and then letting the 
pure crystals isolate out of solution.  
The extraction method that was used is outlined here (with its rationale):  
Step 1: The sample was extracted with sodium bicarbonate, which ionises 
the COOH group on the imide so that it dissolves in the aqueous medium. 
RCOOH + HCO3
-             RCOO- + H2O + CO2 
RCOO- is water miscible, but pyridine and dimethylaminopyridine may also 
dissolve, however there was no insoluble material present after this step of 
the extraction. 
Step 2: The aqueous bicarbonate extract was acidified with 2 mol L-1 
hydrochloric acid to pH 2. This neutralises the acid but ionises all the 
pyridine and aromatic amine (Figure 2-8) 
RCOO RCOOH
NN
H3C
H3C
NN
H3C
H3C
H
N N H
H3CO NH2 H3CO NH3
Non-water 
soluble
Water 
soluble
H
+
H
+
H
+
H
+
+
+
+
 
Figure 2-8: Ionisation of acid and aromatic amine groups in step 2 of extraction 
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Step 3: Two extractions were done with dry dichloromethane (20 mL) in a 
separating funnel. The desired acid imide product can be extracted into 
dichloromethane (as it is not water soluble) and leave the other ionised 
compounds in the water layer. 
Step 4: The two organic fractions were combined and washed with 
distilled water (10mL) to remove any inorganic residues. The combined 
fractions were then dried with granular CaCl2 and filtered. 
Step 5: Removal of dichloromethane under vacuum. 
This yielded light brown crystals (0.201g, 29%, m.p. 259 – 262 oC) of (43); 
found: C, 66.02; H, 6.71; N, 4.01; calculated for C19H23O5N: C, 66.07; H, 
6.71; N, 4.06 %. 1H NMR (300MHz) (CDCl3) (numbering scheme 
illustrated in Figure 2-9): δ 1.27 (d, J = 14.73 Hz, 2H, axial H2 and H6), 
1.32 (s, 3H, H3’), 1.47 (d, J = 12.87 Hz, 1H, axial H4),  2.12 (d, J = 13.57 
Hz, 1H, equatorial H4),  2.16 (s, 6H, H1’ and H5’), 2.83 (d, 2H, equatorial 
H2 and H6), 3.78 (s, 3H, H10’), 6.88 (d, J = 9.18 Hz, 2H, H8), 7.00 (d, J = 
8.52 Hz, 2H, H9). IR (CH2Cl2): 1687 (imide C=O), 1734cm
-1 (carbonyl 
C=O).  
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Figure 2-9: Imide of Kemp's acid, numbered for NMR assignments   
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3 Kinetic studies 
3.1 Introduction 
Kinetic work was started with the overall goal of seeing whether the 
synthesised amide diacid (44) would undergo the desired hydrolysis 
reaction to release amine or whether it would reform imide, a reaction 
which releases no amine and therefore has no prodrug application (Figure 
3-1). This was of concern because similar studies by Billett et al37 on 
cyclopentane aryl amide triacid systems (section 1.4.10) showed that just 
below neutral pH, hydrolysis was minor whereas imide formation was the 
major reaction. The aim was that if hydrolysis was determined to be at 
least the main reaction then the study could be extended further to try and 
determine a pH rate profile across the acid ionisation range for the 
hydrolysis reaction. Figure 3-2 shows an idealised picture of such a rate 
profile assuming the diacid to be hydrolytically more reactive than the 
mono-acid. The focus would be on the pH range of 5.8 – 7.3 as this is the 
region of main interest with respect to prodrug activity, but establishing 
individual rate constants for the neutral and mono-ionised diacid amides if 
their hydrolysis rates are sufficiently different to be dissectible was also of 
key interest for reactivity analysis. In Menger and Ladika’s41 study with 
their tertiary aliphatic amide such dissection was not possible suggesting 
very similar rates for the mono- and diacid species. 
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Figure 3-1: Summary of the reactions studied by kinetic analysis 
3.2 Initial repetitive scanning 
These initial scanning studies were initiated with the ultimate goal of 
seeing whether the Kemp’s amide (58) would hydrolyse to reform the 
original triacid and release amine and/or reform the imide, but as the imide 
initially needed to be opened in basic solution to form the amide (in its 
stable fully ionised state at high pH), this reaction was the one initially 
studied. Subsequent monitoring of the reaction of the triacid amide after 
the pH reduction followed. Some initial repetitive scanning reactions were 
conducted on the impure imide that was first isolated. Further studies 
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including the rate measurements were then done with the purer imide, all 
of which are summarised below.  
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Figure 3-2: Expected pH rate profile for an amide of Kemp's acid 
3.2.1 Kinetic studies on the imide ring-opening reaction  
The studies conducted on this reaction were done on a Kontron Uvikon 
810 spectrophotometer. Initially the ring-opening reaction of the imide was 
studied in 0.04 mol L-1 NaOH, and spectra showed increased absorbance 
at 245 nm which is indicative of the imide being hydrolysed to form the di-
ionised diacid amide (44), but could also additionally represent the amide 
reacting further to form Kemp’s acid (27) and (C6H5)NH2. The spectra were 
55 
 
recorded over fifty and 100-minute intervals and the last scan collected 
after a 250 minute period. The reaction appeared from sequential spectra 
to be a single one from a tight isosbestic point at 233 nm. This suggested 
that only the ring-opening reaction was occurring and that the diacid amide 
product (44) was stable in the conditions in its fully ionised state, which 
was confirmed by the following experiments. 
3.2.2 Lowering of pH to 6.7 
The pH of this solution of ring-opened product was then reduced by 
addition to a KH2PO4 solution to give some neutral solution and buffering. 
This solution was again monitored by repetitive scanning. There were two 
aims in this experiment: 
(i) If the previous reaction had produced the di-ionised diacid amide (44) 
(reaction 4, Figure 3-1) and it was stable at high pH, lowering the pH 
would lead to the mono-ionised species (58) forming, with its hydrolysis 
reaction (reaction 6b, Figure 3-1) (or some other reaction) at pH 6.7 now 
to be expected by analogy with earlier studies of Kemp's amides; whereas 
if the di-ionised amide had already hydrolysed further to amine and 
Kemp's acid at high pH, no further reaction could occur and there would 
be no spectral changes at the lower pH. The results from these scans 
showed there were major spectral changes so this was good evidence that 
they are those of the reaction of the di-ionised amide and that it was the 
stable product of the single-stage alkaline ring-opening reaction. 
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(ii) The spectral changes might show whether the amide was reacting to 
reform the imide (reaction 6a) and/or amine and acid by hydrolysis 
(reaction 6b), the latter as expected from previous studies with Kemp’s 
acid43, 53 in which the aliphatic amides employed were always tertiary so 
were unable to form imides. 
In the event, there was a reaction with a tight isosbestic point at about 233 
nm (which was seemingly coincident with that observed at higher pH for 
the imide to amide reaction). In some preliminary studies this isosbestic 
point had been seen to be lost over time and attributed to the possibility of 
a second reaction. However the change subsequently disappeared when 
a purer sample of the imide was used to make the stock solution, 
indicating the initial importance of absolute sample purity for UV studies 
like these ones. 
3.2.3 Raising pH to 12.4 to check for further imide reaction 
Initially, as a result of the coincidence of the two isosbestic points, a likely 
explanation was initial rapid formation of imide, not hydrolysis. However, 
part of the alkaline diacid amide (44) reaction solution used in this pH-
lowering study had been kept aside and it was reacted again in KH2PO4 
solution. At about the time of the halfway point of the initial reaction at pH 
6.7 this sample was raised back to pH 12.4 (approximately equivalent to 
the pH of the 0.04 mol L-1 NaOH), with the aim of detecting any reversal of 
imide formed back to amide, with increasing absorption as in the initial 
scans referred to above for 0.04 mol L-1 NaOH. As it eventuated, no such 
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reaction was observed which negates the possibility that there was any 
imide now present, and suggests that if any imide is formed at pH 6.7 from 
the amide it must be minimal, or otherwise have reacted itself so quickly at 
this pH that it is not present at the mid-stage of the apparent initial amide 
reaction. This evidence suggests that the coincidence of the isosbestic 
points in the two reactions must indeed be a coincidence, that is to say 
that the actual product of the initial amide reaction, the amide, and the 
imide must all have very similar absorbance intensity (extinction coefficient) 
at 233 nm.  
A similar test was done on the original reaction solution after reaction to 
completion at pH 6.7 in which its pH was raised to 12.4 and the solution 
re-monitored. This also showed the absence of any reaction and therefore 
the absence of any imide at completion. Later, a sample of imide was 
dissolved directly into pH 7 buffer solution and there were no absorbance 
changes over several days; the imide is quite stable at this pH.  
These initial studies showed that the desired amide hydrolysis reaction 
was occurring essentially exclusively as far as could be ascertained at pH 
6.7. This is promising from a prodrug perspective as the hydrolysis 
reaction is the model for prodrug release. The likelihood of anhydride 
formation as the first step of hydrolysis is of no detriment to the prodrug 
potential at this stage as the subsequent anhydride hydrolysis reaction 
would only occur after the cytotoxin release. The analysed amide solution 
shows the amine at its λmax and the lack of UV evidence of a second 
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phase means that the anhydride hydrolysis is either occurring fast relative 
to the amine release or, less likely, that it gives insufficient absorbance 
change in the UV range being monitored (230 – 300 nm) to influence the 
retention of a singe sharp isosbestic point. 
After this positive confirmation of the hydrolysis of Kemp’s diacid amide, 
the next step was to get an initial idea of the rates of reaction which could 
then be accurately determined in the construction of a pH-rate profile. 
3.3 Initial studies on the rate of the ring-opening reaction 
(reaction 4) 
As a complement to the amide hydrolysis study, the kinetics of imide ring-
opening with hydroxide was also studied. This was achieved by monitoring 
absorbance changes of solutions of imide in KOH solutions (0.02 – 0.1 
mol L-1). For second order kinetics (as this reaction is assumed to be), the 
rate constant equation is: 
    Rate = k2 [OH
-] [imide]                          (equation 1) 
However for each reaction [OH-] can be considered constant, as it is in 
large excess over the imide (which may be as low as 10-3 mol), so 
therefore the rate equation becomes pseudo-first order and simplifies to: 
Rate = kobs [imide]                            (equation 2) 
where kobs is the observed pseudo first order rate constant. Thus the ring-
opening reaction can be treated as first order as long as there is a large 
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excess of OH-. Since kobs = k2 [OH
-] from above (equation 2), a plot of kobs 
versus [OH-] will result in a straight line with slope k2 and an intercept of 
zero (Figure 3-4), assuming equation 1 is the correct rate form and there 
is no term of higher order in [OH-]. 
Absorbance data were used to calculate kobs for each run using the infinity 
plot method, as a constant steady infinity absorbance was always 
observed. Some checks were made using the Guggenheim method55, 56, 
but the experimental error was larger. The latter method may have been 
more reliable was there any infinity drift, that is to say if amide reacted 
further to hydrolyse in stronger base, but there was no evidence for such a 
reaction occurring. 
The infinity method involved letting the desired reaction proceed to a time 
where a large number of half-lives have elapsed and there is no further 
absorbance change. At this point the reaction is assumed to have gone to 
completion and the maximum absorbance value has been reached, 
denoted as the infinity value (A∞). By then subtracting all other 
absorbances from A∞ and taking the log10 of this absorbance difference 
(A∞-At), a graph of log10 of the absorbance difference can be plotted 
against time to yield a graph such as the one illustrated below. The slope 
of this is kobs/2.303 from the second order rate constant (a derivation for 
this slope equation can be found in Jencks57). 
The studied reaction was monitored at 243 nm as this is the λmax of the 
product. All plots of log (A∞ - At) versus time were found to be linear and 
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therefore obey first pseudo first order kinetics. An example of such a plot 
is provided in Figure 3-3 with example calculations. The vertical lines on 
the graph represent estimated experimental error in (subtracted) A∞ - At 
values. 
 
kobs = -2.303 x slope = -2.303 x (-0.00177 min
-1) = 0.00408 min-1 
t1/2 = ln(2)/kobs = 170 min 
Figure 3-3: Plot of log (At - A∞) versus time for the ring-opening reaction of (40) at 30
0
C, 
0.100 mol L
-1
 [OH
-
] with error bars, assuming a 5% error in absorbance   
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Table 3-1: kobs (min
-1
), k2 (L mol
-1 
min
-1
), k2 (k2 = kobs/KOH concentration) and half-lives 
(min) for different KOH concentrations, with estimated ± 5% error 
KOH 
Concentration 
(mol L-1) 
kobs (x 10
-3)       
(min-1) 
kobs (x 10
-5) 
(s-1) 
k2 (x 10
-4)    
(L mol-1 s-1) 
Half-
life 
(min) 
0.0200 0.806 ± 0.040 1.34 ± 0.07 6.72 ± 0.34 860 
0.0500 2.17 ± 0.11 3.62 ± 0.18 7.23 ± 0.36 320 
0.0700 3.01 ± 0.15 5.02 ± 0.25 7.12 ± 0.36 230 
0.100 4.08 ± 0.20 6.8 ± 0.34 6.8 ± 0.34 170 
 
 
Figure 3-4: Infinity method plot of [OH
-
] vs. kobs for hydrolysis reaction with error bars 
showing 5% error estimate 
The calculated half-lives vary with [OH-] concentration, from 860 minutes 
at 0.02 mol to 170 minutes at 0.1 mol [OH-] for the infinity method. The 
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intercept is at zero, indicating that the reaction follows pseudo first order 
kinetics and is not subject to complication from any OH-uncatalysed 
release reaction which has been observed with some imides (as 
discussed in section 3.3.1). 
3.3.1 Discussion 
From comparison with the imide ring-opening reactions that were 
observed by Billett and colleagues, he observed much faster rates of 
reaction for the ring-opening reaction of his imide (25a, Figure 3-5) (in its 
dianionic state), with a k2 of 0.57 L mol
-1 s-1 under similar conditions (30.1 
oC, µ = 1.0 mol L-1) and half-lives of 5.9, 11.7 and 26.3 s for KOH 
concentrations of 0.0050, 0.0100 and 0.0200 mol L-1.  
 
N
O O
COOHHOOC
Diacid imide  (25a)
ONO
COOH
OMe
Imide of Kemp's acid (43)  
Figure 3-5: Structures of the Billet et al
37
 imide (25a) and the Kemp's acid imide (43) 
The k2 of the imide in the current Kemp’s case was equal to 0.00067 L 
mol-1 s-1, a reactivity difference of 850 times lower than that found for (25a). 
For the Billett et al37 compound, the two ionised carboxylic acid groups 
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should repel the OH- group that hydrolyses the imide group more than the 
one ionised group present on the Kemp’s mono-ionised acid imide (43). 
However, the positioning of the COO- groups to the imide functionality is 
critical, and the positioning of the carboxylate group in the Kemp’s 
molecule (43) would, from the known all-axial arrangement of acid group, 
be very close to the imide functionality providing more electrostatic 
repulsion than the two more remote COO- groups in (25a). The five-
membered ring structure for (25a) is also less rigid than the Kemp’s 
structure (43) so groups have more freedom to allow OH- less hindered 
attack.  
Studies of imide hydrolysis are scare in the literature. One such study was 
conducted by Behme and Cordes58 on the hydrolysis of the imide group of 
N-acetylsalicylamide in alkaline solution (Figure 3-6). This gave k2 equal 
to 0.0125 L mol-1 s-1 (25 oC), twenty times faster than the hydrolysis rate 
observed for 25a. The reaction mechanism illustrated in Figure 3-6 shows 
how the imide is hydrolysed reversibly by the OH- group. At lower 
concentrations of OH-, the reaction is first order in [OH-] and forms 
salicylamide (62) from a di-ionised state (60) At higher concentrations of 
OH-, the reaction becomes second order and a second equilibrium occurs 
to form the tri-ionised species (61), from which the product amide (62) is 
still formed, but the formation of this intermediate leads to a loss of 
linearity between rate and [OH-] at increasing concentrations of [OH-].. 
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Figure 3-6: Hydrolysis of N-acetylsalicylamide 
3.4 Measurement of first order rate constants for diacid 
amide hydrolysis at different pH’s: Construction of a 
pH rate profile 
Once that the rates for the ring-opening reaction had been measured, it 
was possible to move onto the final phase of the study:  getting a full pH-
rate profile for the hydrolysis reaction. As mentioned previously, no kinetic 
data have been compiled for an aryl amide of Kemp’s acid, so plotting a 
full pH rate profile was of obvious interest for comparison with rate data for 
alkyl and aryl amides of Kemp’s acid and also to determine the prodrug 
applicability of the synthesised Kemp’s mono-ionised acid amide (58) at 
the pH differential between pH 5.8 and 7.3 and also absolute rate. The 
ionisation constants for both acid groups would also be sought from 
inflections in the pH rate profile (Figure 3-2) as long as the rates for non-
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ionised and mono-ionised diacid amides were sufficiently different. In this 
context it was noticeable however, that Menger and Ladika observed only 
one apparent ionisation curve in the pH rate profile of their aliphatic diacid 
amide (29). 
The spectra were recorded over varying time intervals, from 40000 
seconds for low pH analysis to 210000 seconds for high pH analysis. 
These time scales were chosen to incorporate at least 10 half-lives of the 
hydrolysis reaction. The analysis was conducted on a Hewlett-Packard 
Agilent 8453 UV/Vis spectrophotometer which as a diode-array instrument 
records full spectra at every pre-set time interval. Spectra and calculations 
were obtained with Agilent Chemstation software. The analysis was 
conducted using the first order kinetics method option in the software, 
which plots an exponential graph according to equation 3 
 a + b e(-kt)                                  (equation 3) 
which allows kobs (with standard deviation) to be calculated directly at any 
wavelength, the wavelengths of interest being 200 – 350 nm in this case, 
with a best fir curve fitted to data plotted as absorbance versus time. The 
absorbance data at 250 nm, where absorbance changes was at a 
maximum, were routinely used to calculate the rate constants. An example 
of a typical spectrum obtained by this analysis is shown in Appendix II. 
Other rate constants calculated using data from wavelengths in the 240 – 
260 nm range always showed the same rate constants within experimental 
error. 
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Therefore the infinity data were not used because of over-emphasis on 
small absorbances at the late stages of the reaction in the curve fitting, but 
the analyses were conducted so that stable infinity values could be seen 
to ensure there was not any problem of drift which would affect the 
reaction rates calculated by the software. 
Mono-potassium di-hydrogen phosphate and di-potassium hydrogen 
phosphate buffer solutions were used in varying ratios (Table 3-3) to make 
the buffers from pH 5.8 to 7.8. The lower the pH leads to increased rates 
of reaction as there is more un-ionised carboxylic acid groups which react 
intramolecularly to hydrolyse the amide (section 1.4.6). 
For analysis at pH 4.5 – 5.8, mono-potassium (HOOCCH2COOK) and di-
potassium ((KOOC)2CH2) analogues of malonic acid were used. For lower 
pH analysis (pH 2.8 – 4.5), buffers were prepared by direct addition of 
excess malonic acid to KOH. 
For the run at low pH (pH 0.5), standardised hydrochloric acid was added 
directly to boiled distilled water.  
All of the rate constants obtained from these analyses were combined and 
plotted as log k versus pH to obtain a pH rate profile (Figure 3-7). A table 
of the calculated rate constants at each pH used to plot the pH rate profile 
can be found in Appendix II. 
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3.4.1 Buffer dilutions 
Buffer solutions were normally used at 0.100 mol L-1 to ameliorate the 
effect of adding a high alkaline solution to start the reaction, even if only in 
small volumes. At this buffer concentration there was interest in what 
effect buffer catalysis may have on the rates of the hydrolysis reaction. 
Buffer catalysis is known to occur for some aryl amides with neighbouring 
carboxylate groups51, so conducting a study on the possible effect that the 
buffer may have in this case was of obvious interest.  
Buffer dilution analysis was carried out by halving or quartering the buffer 
concentration (in this case for the 1:1 phosphate buffer solution) and 
analysing the solution with half or a quarter as much of a regular injection 
of the ring-opened amide solution so that pH was retained. If no buffer 
catalysis was occurring, then there would be no change in the rate of 
reaction with concentration, but if buffer catalysis was occurring, then the 
rate would be of a lesser magnitude and the reaction rates for the other 
buffer solutions of full buffer concentration would have to be checked 
accordingly. 
The resulting rates were found to be consistent with those calculated for 
solutions with full buffer concentration so buffer catalysis was not 
occurring to a measurable extent. The rate constants for the buffer 
dilutions are illustrated in Figure 3-7, with the red points indicating the rate 
constants of a two-fold buffer dilution (buffer concentration = 0.050 mol L-1) 
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and the purple points indicating the rate constants of a four-fold buffer 
dilution (buffer concentration = 0.0250 mol L-1). 
A buffer dilution run was also carried out on the 0.050:0.050 mol L-1 
malonic acid solution to see if this showed any buffer catalysation. This 
involved a two-fold dilution which showed a negligibly higher rate constant 
than that observed for the full concentration run, which can be attributed to 
the diluted solution having a slightly lower pH, so buffer catalysis is not 
occurring for the malonic acid buffer solutions. 
 
  
6
9
 
 
Figure 3-7: pH rate profile (log k versus pH) for the hydrolysis of the mono-ionised amide (phosphate buffer dilutions: red = ½ x buffer dilution, purple = ¼ x buffer 
dilution, malonic acid buffer dilution: black = ½ x buffer dilution) 
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3.4.2 Results 
The pH rate profile (Figure 3-7) shows what appears to be a single 
ionisation curve at the pH of interest with respect to prodrug application. 
This corresponds to one carboxyl group being protonated and participating 
in the hydrolysis reaction. A plot of the type that Menger and Ladika41 used 
to calculate the pKa for their aliphatic amide is adapted in Figure 3-8. As 
only one carboxyl group participates in the hydrolysis reaction this plot can 
be analysed by equation 4 (derivation of equation 4 is shown in 
Appendix III): 
1 / k2 = (Ka / klim [H
+]) + 1 / klim                   (equation 4) 
Where klim is the rate at 100% conjugate acid and Ka is the carboxylate 
group ionisation constant. As equation 4 takes the form y = mx + c, a plot 
of 1 / k2 versus 1 / [H
+] will give an intercept of 1 / klim and slope of Ka / klim.  
At pH below 2, there is seen to be a sharp increase in rate. The pH is too 
low for this to represent an increase corresponding to the ionisation of the 
second acid group. The same increase in reactivity below pH 2 was 
observed by Kluger and Lam,51 and is most likely due to H+ catalysation of 
the reaction. 
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klim = 1 / intercept = (12633 s)
-1 = (7.9 ± 0.8) x 10-5 s-1 
slope = Ka / klim, Ka = slope x klim = (0.0024 ± 0.00024) L mol
-1 x (7.9 ± 0.8) 
x 10-5 s-1 
= (1.9 ± 0.4) x 10-7 L mol-1 s-1 
pKa = -log Ka = -log ((1.9 ± 0.4) x 10
-7 L mol-1 s-1) = 6.72 ± 0.09  
Data has assumed ± 10% error in the slope and intercept values 
Figure 3-8: plot of 1/k versus 1/[H
+
] over the pH range 4.5 – 7, data taken form Figure 
3-8 with assumed ± 5% error in 1/k, adapted from Menger and Ladika
41
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3.4.3 Discussion 
3.4.3.1 Calculated pKa value 
The data over the pH range 4.5 – 7, are approximately linear, suggesting 
just one ionisation is operating, or if not, there is little difference in rate 
between the mono- and diacid forms. This coincidence is unexpected, 
except that similar was observed for aliphatic amide profiles,41, 43 with no 
sign there either of the first ionisation down to pH 2, as likewise observed 
here. 
Although there is no data is available for the ionisation constants of 
Kemp’s acid, the pKa value of 6.72 is high for an acid, and suggests that 
some stabilisation effect must be operating in the molecule to provide 
stability in a mono-ionised state. Such an interaction could be an 
interaction between the non-ionised carboxylate group and the ionised 
carboxylate group. This stabilisation factor could lead to the initial 
ionisation occurring easily as the mono-ionised state is in such a stable 
conformation. Similar systems such as that studied by Menger and Ladika 
show a pKa value of 6.9 ± 0.4 for their tertiary alkyl amide (29), based 
again on single ionisation analysis in the absence of any evidence for 
another low pH rate plateau.   
3.4.3.2 Previous rate study comparisons 
The reaction rates for the secondary amide compare well to the secondary 
aliphatic amide (33b) and secondary amide methyl ester (35) (Figure 3-9) 
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synthesised by Curran et al,43 which had half-lives of 270 hours at pD 7 
(22 oC) whilst at pH 6.6 (31.6 oC) the hydrolysis reaction for the mono-
ionised amide acid (58) occurs with a half-life of just under four hours, a 67 
fold faster reactivity difference. This is good evidence for the higher rate of 
reactivity of aryl compared to alkyl amides. 
COOH
H3C
H3C
CH3
COOH
O N
H
CH2CH2Ph
COOH
H3C
H3C
CH3
COOMe
O N
R
CH2CH2Ph
(33b) (35)  
Figure 3-9: Two secondary amides synthesised by Curran et al
43
 
 Literature comparisons on the reactivity differences between secondary 
alkyl and aryl amides are scarce. One study that has been conducted was 
by Kirby and Lancaster59 on substituted maleamic acids (Figure 3-10). 
The results of this study showed that the rate of amide hydrolysis from pH 
0 – 5 for the aryl maleamic acid (59a) to be equal to 2.4 x 10-2 s-1, six times 
higher than for the rate for the alkyl analogue (59b) which is equal to 3.9 x 
10-3 s-1. This difference in reactivity between aryl and alkyl amides 
suggests the likelihood of more generally higher rate of reaction of aryl 
amides compared to alkyl amides. 
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Figure 3-10: Substituted maleamic acids studied by Kirby and Lancaster
59
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Figure 3-11: Tertiary amide (33a) studied by Curran et al
43
 
The pseudoallylic strain proposed by Curran et al43 for the high rate of 
reaction of the tertiary amide (33a, Figure 3-11) is unlikely to be occurring 
for the Kemp’s mono-acid amide. For (33a) it is the presence of two bulky 
groups that cause the pseudoallylic strain, as the carbon to nitrogen bond 
can rotate to provide a conformation that has the least amount of steric 
strain. The least bulky methyl group on the tertiary amide nitrogen is 
situated close to the methyl group on the quaternary carbon in the ring 
structure preferentially over the larger alkyl group providing a conformation 
with the less amount of steric strain, however this conformation causes 
amide bond distortion due to the interaction between the two methyl 
groups, a distortion which is known to accelerate the rate of amide 
hydrolysis.44 Such an interaction cannot occur for (58) as there is only one 
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bulky group on the amide nitrogen (in the form of the aromatic group) with 
the other group being a hydrogen, so the bond can rotate to move the less 
bulky hydrogen atom into a position which gives less steric strain. A 
possible interaction that may be occurring to retard the rate of hydrolysis in 
(58) could be a hydrogen bonding interaction between the amide hydrogen 
and the acid group, which would decrease the rate of reaction by 
rendering the amide carbonyl less able to react with the oxygen of the 
unionised carboxylic acid group which is needed to initiate anhydride 
formation and amine release (Figure 3-12). 
HOOC
N O
Ph-OMe
H
OO
Me
Me
Me
 
Figure 3-12: Possible interaction between amide hydrogen and an acid group in the 
Kemp’s mono-ionised acid amide molecule (58) 
3.4.3.3 Prodrug applicability and advantages (if any) of aryl vs. alkyl amides 
With respect to prodrug applicability, the hydrolysis reaction shows a 
reactivity difference between pH 5.8 and pH 7, with a half-life of 506 
minutes at pH 7.07 and a lower half-life of 162 minutes at pH 5.8, roughly 
one third as fast as at the higher pH. The half-life at the lower pH is too 
long for potential prodrug use at this stage, as ideal half-lives for prodrug 
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diffusion into cells in a tumour upon cytotoxin release have been 
calculated to be in the range of many seconds to a few minutes60, as this 
allows for as many cytotoxic molecules as possible to attack the hypoxic 
cells, maximising the efficiency of a prodrug. Having such a high half life 
here would mean decreased efficiency and also could mean possible 
diffusion of the released active cytotoxin into normal healthy bodily tissues 
via the bloodstream.  
The main hindrance to prodrug potential however, is the difference in 
reactivity at the two pHs of interest not being of a great enough magnitude, 
as by the time that three half-lives of the cytotoxin release had occurred at 
lower pH, the cytotoxin would also start to be released at higher pH 
throughout the rest of the body. Although the illustrated doxorubicin 
system (41d) had the same problem of low reactivity at lower pH (pH 5), it 
had a large difference in reactivity between pH 5 and pH 7, having a half-
life of over 100 days at the higher pH, 60 times slower compared to the 
half-life at lower pH. This is the type of reactivity difference that would be 
ideal for any possible future application of prodrugs utilising the Kemp’s 
acid scaffold.  
The reaction rates of the tertiary and secondary amides synthesised by 
Curran et al43 (section 1.5.1) showed rate differentials ranging over 
several orders of magnitude (from 102 – 104) slower for the secondary 
amide derivatives. Applying the lower differential in rate (102) to tertiary 
and secondary analogues of the mono-ionised Kemp’s amide (58), this 
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would mean a decrease in half-life from 162 minutes for a secondary 
amide at pH 5.8 to a possible half-life of one and a half minutes for a 
tertiary amide, a time which is much more suited to prodrug applicability. 
Applying the same hypothetical rate differential to the rate at higher pH 
(pH 7), the half-life time would decrease from 506 minutes to five minutes. 
Of course, this hypothetical comparison is reliant on the presence of the 
same pseudoallylic strain in a tertiary amide of Kemp’s acid as there was 
in the molecules studied by Curran et al43. Also, the tertiary amides 
synthesised by Curran et al43 were aliphatic, so comparison of aryl and 
aliphatic systems may be unreliable, but at least it gives some hope that 
the Kemp’s acid system may be suited to prodrug applicability if tertiary 
amides can be synthesised. The rates of tertiary aryl amides may be even 
faster than in the comparisons illustrated above due to the faster overall 
reaction times of aryl systems compared to alkyl systems. These 
hypothetical reaction times are similar to those found for similar tertiary 
amides such as the amide studied by Glusenkamp et al35 (22a) which had 
a half-life of 30 seconds at pH 6 and 2.4 minutes at pH 7, and are much 
better suited to the needs of a prodrug system. 
From the evidence previously illustrated it seems that to get a molecule 
that is reactive enough at the lower pH of interest, a tertiary amide of 
Kemp’s acid is needed. As touched on earlier in this discussion, the 
reaction rate of a tertiary aryl amide derivative could have a half-life of 
roughly a minute, an ideal time for prodrug use. Any possible structural 
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modifications that could be carried out are covered in the extensions and 
conclusions chapter below. 
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3.5 Experimental 
3.5.1 Buffer and other solution preparations  
Distilled water for buffer solution preparation was boiled under nitrogen 
flow for 30 minutes then cooled under nitrogen to remove all carbon 
dioxide. A soda lime tube was attached upon cooling to prevent any 
atmospheric carbon dioxide re-entering the solution. All glassware that 
was used was washed in an acid bath.  
KOH to be used was standardised by titration with standard HCl using 
phenolphthalein as an indicator. It was found that a solution that was 
thought to be made to 0.200 mol L-1 has a true concentration of only 0.160 
mol L-1, so any further solution made with the KOH would have to contain 
1.25 times as much KOH as originally calculated. 
Kinetic studies were performed on a Hewlett-Packard Agilent 8354 diode-
array spectrophotometer first order rate constants were calculated by the 
Agilent Chemstation software in the kinetics mode 
3.5.2 Amide solution preparation and kinetic methods 
The imide (43) (17 mg) was placed in 0.5 mL of 0.500 mol L-1 NaOH and 
reacted for 10 half-lives at 30 oC to ensure that the ring-opening reaction 
had gone to completion and the di-ionised acid amide group was present. 
To initiate the hydrolysis reaction a small volume of this solution (10 µL), 
was added to roughly 2.5 mL of 0.100 mol L-1 phosphate buffer solutions 
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of varying pH within a temperature pre-equilibrated silica cell in the 
spectrophotometer, and analysed in the UV/Vis spectrum between 200 - 
350 nm. The scans showed the previously observed isosbestic point at 
233 nm. The reaction was thermostatted at constant temperature. 
For the buffer solutions, KCl, monopotassium dihydrogen phosphate and 
di-potassium hydrogen phosphate solutions (0.200 mol L-1) were prepared 
by weight. Solid KCl was dried overnight in an oven and then the solid was 
added to 500 mL of the boiled water to make a 2.00 mol L-1 solution. The 
monopotassium dihydrogen phosphate solution was prepared by some of 
the solid to 100 mL of the boiled water. The di-potassium hydrogen 
phosphate was made by some of the solid to 100 mL of the boiled water.  
pH 5.8 – 7.8 buffers were made up to 20 mL with combinations of 
monopotassium dihydrogen phosphate and di-potassium hydrogen 
phosphate solutions (0.200 mol L-1). With KCl (2.00 mol L-1) added in 
volumes sufficient to maintain the total ionic strength of solution at 1.00 
mol L-1. Finally, H2O was added to make the volume up to 20 mL (Table 
3-3). The ionic strength (µ) of the solution was calculated using equation 
5: 
µ = ½ Σ (ci zi
2)                                (equation 5) 
(where ci = concentration of ion i in solution and zi is the charge of i in 
solution), an example calculation is given below for a 0.100 mol L-1 
phosphate buffer solution. 
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Table 3-2: Table of values used to prepare a 20 mL 1:1 phosphate buffer solution, with 
calculations for ionic strength (underlined values calculated as shown below) 
Buffer species 
Buffer 
concentration 
(mol L-1) 
Volume (mL) 
Ionic strength 
(µ, mol L-1) 
KH2PO4 0.200 5 0.050 
K2HPO4 0.200 5 0.150 
KCl 2.00 8 0.80 
H2O - 2 - 
 
Using equation 5: 
For KH2PO4: µ = ½ Σ ([K
+] x 12) + ([H2PO4
-] x 12) = ½ Σ (0.05 mol L-1 x 12) 
+ (0.05 mol L-1 x 12) = ½ (0.10 mol L-1) = 0.050 mol L-1 
For K2HPO4: µ = ½ Σ (2 [K
+] x 12) + ([HPO4
2-] x 22) = ½ Σ ((2 x 0.05 mol L-1) 
x 12) + (0.05 mol L-1 x 22) = ½ (0.30 mol L-1) = 0.150 mol L-1 
Combining the two values gives a contribution of 0.20 mol L-1 from the 
buffer species towards the overall ionic strength. Therefore 0.8 µ is 
needed from KCl to make the ionic strength equal to 1 mol L-1. 
So 8 mL of 2.00 mol L-1 KCl diluted in the 20 mL will bring the ionic 
strength to 1 mol L-1, as: 
µ = (8 mL / 20 mL) x 2 mol L-1 = 0.8 mol L-1  
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The remaining 2 mL needed to make the solution up to 20 mL comes from 
using the boiled distilled water.   
Table 3-3: Table of volumes used to make 20 mL phosphate buffer solutions for pH 5.8 to 
7.8 analysis (all volumes in mL) 
Buffer ratios 
(KH2PO4 : 
K2HPO4) 
KH2PO4  (0.200 
mol L-1) 
K2HPO4  
(0.200 mol L-1) 
KCl           
(2.00 mol L-1) 
H2O 
1 : 9 1 9 7.2 2.8 
1 : 7 1.25 8.75 7.25 2.75 
1 : 3 2.5 7.5 7.5 2.5 
1 : 1 5 5 8 2 
3 : 2 6 4 8.2 1.8 
3 : 1 7.5 2.5 8.5 1.5 
4 : 1 8 2 8.6 1.4 
 
For pH analyses from pH 4.5 to 5.8, malonic acid buffers were used. By 
adding different amounts of the malonic acid to KOH, different ionisations 
states of the malonic acid could be obtained. 2.081 g (0.0200 mol) of the 
malonic acid was added to 20 mL of KOH (1.00 mol L-1) and made up to 
100 mL with KCl (2.00 mol L-1) yielding the mono-potassium dihydrogen 
malonic acid (HOOCCH2COOK) (0.0200 mol L
-1). Adding the same 
amount (0.0200 mol) of malonic acid to 40 mL of KOH and making up to 
100 mL with KCl yielded the di-potassium hydrogen malonic acid 
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((KOOC)2CH2) (0.0200 mol L
-1). As for the phosphate buffer solutions, 
combining these two buffer solutions in different ratios meant that different 
pHs could be achieved. KCl was again added in volumes sufficient to 
maintain the ionic strength at 1 mol L-1, with the boiled water added to 
make the solution up to 20 mL (Table 3-4). 
Table 3-4: Table of volumes used to make 20 mL malonic acid buffer solutions for pH 4.5 
– 5.8 analysis (all volumes in mL) 
Buffer ratios 
(HOOCCH2COOK: 
((KOOC)2CH2) 
HOOCCH2COOK 
(0.0200 mol L-1) 
 (KOOC)2CH2 
(0.0200 mol L-1) 
KCl 
(2.00 
mol L-1) 
H2O 
2 : 3 4 6 7.8 2.2 
1 : 1 5 5 8 2 
3 : 2 6 4 8.2 1.8 
3 : 1 7.5 2.5 8.5 1.5 
9 : 1 9 1 8.8 1.2 
 
For pH analysis at pH 2.7 - 4.5, a constant amount of malonic acid solid 
(0.2081g, 0.05 mol) was added directly to varying concentrations of KOH 
with the ionic strength maintained at 1 mol L-1 by addition of KCl. Finally 
H2O was added to make up the volume to 20 mL. 
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Table 3-5: Table of volumes used to make 20 mL buffer solutions for low pH (4.5 – 2.7 
pH) analysis (all volumes in mL) 
HOOCCH2COOK 
Concentration 
(mol L-1) 
(KOOC)2CH2 
concentration 
(mol L-1) 
Volume 
KOH (1.00 
mol L-1) 
Volume 
KCl (2.00 
mol L-1) 
Volume 
H2O 
0.0500 - 1 9 10 
0.0300 0.0200 1.4 8.6 10 
0.0100 0.0400 1.8 8.2 10 
 
For the run at very low pH (pH 0.5), a 1 mol L-1 HCl run was used. To 
prepare this buffer solution, standardised HCl (1.014 mol L-1, 8.85 mL) was 
added to boiled distilled water (11.15 mL) to make a 20 mL volume. 
3.5.2.1 Buffer dilutions 
For a two-fold dilution of the phosphate buffer, the buffer concentration 
was reduced to 0.050 mol L-1 and 5 µL of the ring-opened imide solution 
was injected. For a four-fold dilution the concentration was reduced to 
0.0250 mol L-1 and 2.5 µL of the ring-opened amide solution was added. 
For a two-fold dilution of the malonic acid solution, the buffer concentration 
was reduced to 0.0250 mol L-1 and 5 µL of the ring-opened imide solution 
was injected. 
 85 
 
4 Conclusions and project extension  
4.1 Extension: suggestions for future research 
As mentioned previously, the synthesis of a tertiary amide of Kemp’s acid 
would be of great interest with regard to prodrug applicability, now that the 
reactivity of an aryl amide of Kemp’s acid has been shown to be greater 
than that of a like alkyl amide. Also documented, in chapter two, are the 
attempts at trying to synthesise such a tertiary amide from methods 
present in the literature, attempts which failed to produce any of the 
desired product. Another option available is direct conversion of the 
secondary amide into a tertiary amide. There are many methods for both 
alkylation and acylation of the amide nitrogen at acidic,61 neutral and basic 
conditions, which are extensively reviewed.62, 63 For the Kemp’s system, 
the conversion into a tertiary amide would have to occur at higher pH, as 
this is where the amide is in its stable dianionic form (44). Also, as the 
amide at higher pH is in a molecule that has already two ionised 
carboxylate groups, a strong base would also be needed to deprotonate 
the amide nitrogen.  
Changing the structure from a secondary to a tertiary amide will however 
most likely not change the pKa values to much extent, so the relative rates 
at ph 5.8 versus pH 7 would be similar still and rate difference would most 
likely need adjustment. The cis,trans secondary amide (37b) synthesised 
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by Curran et al43 showed a pKa value of 4.39, which is lower than that of 
the cis,cis isomer (33b) which had a pKa of 5.45. Thus possible 
modification of one of the axial groups on the Kemp’s amide molecule 
could result in a decrease in pKa, such that the relative rates of reactivity in 
the required pH sensitivity zone would be larger.  
One method of amide conversion is outlined in Figure 4-1, where a 
secondary aryl amide (60) is converted to a tertiary aryl amide (61) using 
sodium amide as a strong base and then reacting the deprotonated amide 
with an electrophile. This reaction had a good yield of 67.5 %.64 
Cl
O2N
NH
C O
CH3
(a) NaNH2
(b) ClC2H4N(C2H5)2
Cl
O2N
N
C
CH3
CH2CH2N(C2H5)2
(60) (61)
O
 
Figure 4-1: Conversion of a secondary amide to tertiary amide 
Following a synthesis of an amide of Kemp’s acid with high enough rate of 
reactivity, the next logical step in an extension would be the attachment of 
a cytotoxic species. A molecule that could be attached is one previously 
studied by Kelly65 and also Atwell et al66. This research was concerned 
with the synthesis of a seco-cyclopropylbenzindoline (CBI) (64) prodrug by 
attaching an indole effector (62) to a gem-dimethylated acid (63) (Figure 
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4-2). The R group on (62) was varied as shown in Table 4-1, which 
showed that the group with the greatest cytotoxicity is that with an NHMe 
at the R position. The effect of the R group on toxicity can be seen from 
the table, with a 4000 fold range of cytotoxicity observed for the four 
analogues. The synthesis of this molecule was achieved under relatively 
easy conditions, although purification was an issue and a small yield of 
15% was obtained. The obvious potential of the molecule (62b) cannot be 
ignored, and so possible attachment of this molecule to the Kemp’s acid 
scaffold would be of great interest. 
Table 4-1: Growth inhibition of AA8 cells, following four hour drug exposure
66
 
Compound R group IC50 (nM) 
62a NO2 1600 ± 500 
62b NH2 0.43 ± 0.05 
62c NHMe 0.17 ± 0.02 
62d NMe2 5.6 ± 0.6 
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Figure 4-2: Synthesis of a CBI prodrug (64) 
Another potential cytotoxin that could be utilised on the Kemp’s acid 
scaffold is that of doxorubicin. The doxorubicin system illustrated in 
section 1.5.2 shows good potential for prodrug applicability, and has 
already been attached to the Kemp’s acid scaffold, so further research 
using this molecule would be relatively simple. The researchers of the 
doxorubicin system did not give any reason as to why the huge rate 
differential was observed between pH 5 and 7 for the secondary amides 
(41b) and (41d), as well as why the tertiary amide (41c) had such a 
retarded rate of reaction. Also testing the reactivity of these compounds at 
the slightly higher pH of 6 would be of interest as this is the pH with 
respect to prodrug applicability. 
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4.2 Summary and conclusions 
The pH rate profile of the Kemp’s secondary amide (58) fits a model of 
neighbouring group catalysis by a single non-ionised group, with a limiting 
rate constant at lower pH of 7.9 x 10-5 s-1, and a calculated pKa of 6.72. 
This pKa value is in good agreement with that calculated by Menger and 
Ladika41 for their tertiary pyrrolidyl amide, which had a pKa of 6.9. The 
calculations used to derive these pKa values are subject to some 
uncertainty due to the absence of a different limiting plateau for the neutral 
amide di-acid at lower pH which if it were apparent and extricable from the 
higher pH data might have allowed some correction to klim and pKa for the 
mono-ionised acid amide (58). 
Irrespective of the difficulty with quantitative interpretation, the rate of 
amine release from the prodrug model at extracellular tumour pH of 5.8 
had a half-life of 162 minutes compared with a half-life of 502 minutes at 
pH 7 (taken to be the normal intracellular pH), a roughly three fold 
difference in reactivity. This reactivity difference is not large enough 
however for any potential prodrug application at this stage. The type of 
reactivity difference that is needed is of greater magnitude, so that the 
molecule is highly stable for a long period of time in the body at large, as 
this would decrease the possibility of side-effects occurring. This 
difference in reactivity, and also the overall speed of the reaction is too 
slow for potential prodrug applicability (Denny calculated a diffusion time 
of seconds to a few minutes upon prodrug activation in a tumour for 
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maximum effect60). Thus this secondary amide of Kemp’s acid is not 
suited to prodrug applications.  
As discussed, tertiary amides of Kemp’s acid (such as 29, 31, 33a and 
37a, as discussed in section 1.5.1) have higher relative rates to that of 
similar secondary amides, due to strain effects present in the structure of 
the tertiary amide molecules. Therefore, for further studies on Kemp’s acid, 
it seems the most fruitful path for further prodrug related research would 
be that of conversion of the secondary amide to a tertiary amide. Many 
such methods are available in the literature, and some are discussed 
previously in section 4.1.  
However, such a conversion to a tertiary amide would not significantly 
alter the pKa value for the second dissociation constant, which is too high 
for large enough rate discrimination. Structural modifications on the 
Kemp’s scaffold could be envisaged such as that done on the doxorubicin 
system (41c) in section 1.5.2, where the R group on the amide nitrogen 
was varied, although to limited effect. This structural modification would be 
initiated with the goal of lowering the pKa but increasing the absolute rate 
of reaction to compensate for the effect of lower pKa on absolute rate at pH 
5.8 versus 7 would be a useful target. 
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Appendix I 
 
Plot of absorbance versus wavelength (nm) for a 1:1 phosphate buffer run (note the 
observed isosbestic point at 233 nm) 
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Appendix II 
Table of data used to plot the pH rate profile (Figure 3-7) 
Buffer solution ratio pH k (s-1) Error in k (s-1) 
KH2PO4 : K2HPO4    
1 : 9 7.84 8.99 x 10-6 4.0 x 10-7 
1 : 9 7.72 1.01 x 10-5 1.0 x 10-6 
1 : 9 7.68 1.21 x 10-5 1.3 x 10-6 
1 : 7 7.37 1.52 x 10-5 6.6 x 10-7 
1 : 7 7.37 1.57 x 10-5 9.4 x 10-7 
1 : 7 7.36 1.42 x 10-5 3.6 x 10-7 
1 : 7 7.35 1.38 x 10-5 3.0 x 10-7 
1 : 7 7.35 1.27 x 10-5 3.6 x 10-7 
1 : 3 7.07 2.28 x 10-5 6.6 x 10-7 
1 : 3 6.96 2.98 x 10-5 1.1 x 10-6 
1 : 3 6.94 2.83 x 10-5 8.9 x 10-7 
1 : 3 6.92 3.33 x 10-5 1.2 x 10-6 
1 : 3 6.91 3.18 x 10-5 8.4 x 10-7 
1 : 1 6.62 4.80 x 10-5 6.5 x 10-7 
1 : 1 6.61 4.88 x 10-5 5.6 x 10-7 
1 : 1 6.6 4.90 x 10-5 6.2 x 10-7 
1 : 1 6.58 4.36 x 10-5 9.6 x 10-7 
1 : 1 6.57 4.17 x 10-5 3.3 x 10-6 
1 : 1 6.57 4.14 x 10-5 6.9 x 10-7 
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1 : 1 6.52 4.63 x 10-5 4.3 x 10-7 
1 : 1 6.42 4.95 x 10-5 7.8 x 10-7 
1 : 1 6.42 4.99 x 10-5 9.1 x 10-7 
1 : 1 (½ x buffer 
dilution) 
6.56 4.96 x 10-5 1.6 x 10-6 
1 : 1 (½ x buffer 
dilution) 
6.52 5.15 x 10-5 1.8 x 10-6 
1 : 1 (¼ x buffer 
dilution) 
6.48 4.89 x 10-5 1.3 x 10-5 
1 : 1 (¼ x buffer 
dilution) 
6.45 5.00 x 10-5 1.7 x 10-5 
3 : 2 6.26 5.34 x 10-5 1.5 x 10-6 
3 : 2 6.26 5.37 x 10-5 2.4 x 10-6 
3 : 2 6.25 5.40 x 10-5 3.1 x 10-6 
3 : 1 6.05 6.29 x 10-5 4.2 x 10-7 
3 : 1 6.04 6.49 x 10-5 7.3 x 10-7 
4 : 1 5.91 7.32 x 10-5 1.3 x 10-6 
4 : 1 5.9 6.69 x 10-5 8.4 x 10-7 
4 : 1 5.87 6.99 x 10-5 4.8 x 10-7 
4 : 1 5.86 7.1 x 10-5 4.5 x 10-7 
HOOCCH2COOK: 
(KOOC)2CH2 
   
2 : 3 5.65 7.25 x 10-5 2.6 x 10-6 
2 : 3 5.64 7.29 x 10-5 3.4 x 10-6 
2 : 3 5.62 7.68 x 10-5 3.8 x 10-6 
1 : 1 5.35 7.59 x 10-5 4.3 x 10-7 
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1 : 1 5.30 7.82 x 10-5 5.1 x 10-7 
3 : 2 5.27 7.88 x 10-5 7.3 x 10-7 
3 : 2 5.25 8.12 x 10-5 1.0 x 10-6 
3 : 2 5.24 7.92 x 10-5 8.4 x 10-7 
3 : 1 4.89 8.25 x 10-5 2.5 x 10-6 
3 : 1 4.87 8.04 x 10-5 2.1 x 10-6 
3 : 1 4.86 8.20 x 10-5 1.4 x 10-6 
9 : 1 4.6 8.43 x 10-5 1.8 x 10-6 
9 : 1 4.59 8.16 x 10-5 6.0 x 10-7 
9 : 1 4.57 8.57 x 10-5 8.8 x 10-7 
Solid malonic acid 
runs 
   
HOOCCH2COOK: 
(KOOC)2CH2 
   
0.010 : 0040 mol L-1 3.70 8.80 x 10-5 1.4 x 10-6 
0.030 : 0.020 mol L-1 3.16 1.00 x 10-4 1.4 x 10-6 
0.050 : 0 mol L-1 2.74 1.15 x 10-4 1.0 x 10-6 
0.050 : 0 mol L-1 (½ x 
buffer dilution) 
2.62 1.22 x 10-4 2.0 x 10-6 
1 mol L-1 HCl runs    
1 mol L-1 HCl 0.49 2.10 x 10-3 1.3 x 10-5 
1 mol L-1 HCl 0.48 2.09 x 10-3 1.0 x 10-5 
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Appendix III  
Derivation of the linear relationship between 1 / k and 1 / [H+] used to 
obtain klim and Ka (equation 4, page 70) 
1 / k2 = (Ka / klim [H
+]) + 1 / klim                   (equation 4) 
klim is the rate for acid at 100 % conjugate acid (in the case of this 
application this term represents the fully protonated amide mono-anion 
(58)), assuming no reaction of ionised acid group form (in this case the di-
ionised amide (44), which is known to be stable at pH 12). Since the 
observed rate constant will depend on the fraction of amide in the reactive 
(mono) acidic form, 
kobs = f x klim                                             (equation 6)  
where f is the fraction of the reactive acid form: 
f = [RCOOH] / ([RCOOH] + [RCOO-]) 
1 / f = ([RCOOH] + [RCOO-]) / [RCOOH] 
 = 1 + [RCOO-] / [RCOOH]                   (equation 7) 
The dissociation constant Ka is given by: 
Ka = [RCOO
-] [H3O
+] / [RCOOH] 
whereby: 
 [RCOO-] / [RCOOH] = Ka / [H3O
+] 
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Inserting this term into equation 7 we get: 
1 / f = 1 + Ka / [H3O
+]                     (equation 8) 
From equation 6: 
kobs = f x klim        
1 / kobs = (1 / f) x (1 / klim) 
Inserting equation 8 into this expression yields: 
1 / kobs = (1 + Ka / [H3O
+]) x 1 / klim 
= Ka / klim x 1 / [H3O
+] + 1 / klim 
Simplifying this equation gives equation 4: 
1 / kobs = Ka / klim [H3O
+] + 1 / klim                       (equation 4) 
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